These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000050-23 Prospective, double-blind, randomized, placebo-controlled dose finding study of the efficacy and safety of 2 target doses of Org 34517 used as adjunctive therapy in subjects with psychotic major depre... 2006-07-17 due-trials
Completed, but no date, and reported results 2004-000073-64 A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Assess the Effects of L-000124467 on Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis as Measured by MR... bad-data
Completed, but no date, and reported results 2004-000074-31 A Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, Safety, and Tolerability of L-000124467 in Rheumatoid Arthritis Patients bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000120-32 Early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome a randomized, placebo-controlled trial evaluating the clinica benefits of early front-loated Eptifibatide in... 2009-08-28 bad-data
Reported results 2004-000311-26 A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus who Have Inadequate Glycemic Control on Pioglitaz... 2005-11-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-000312-93 A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin... 2007-03-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000313-19 A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of MK-0431 Monotherapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control 2007-03-09 bad-data
Ongoing, reported early 2004-000390-59 Safety and efficacy of SCH 417690 in HIV-infected treatment-naive subjects not-yet-due
Ongoing, reported early 2004-000424-32 A Multicenter, Open, Noncomparative Study to Estimate the Safety, Tolerability, and Efficacy of Caspofungin Acetate in the Treatment of Adults with Invasive Candida Infections (Excluding Patients with... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-000469-36 A multicenter, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the efficacy and safety of four different doses of Org 50081 in the treatment of moderate to severe vasomo... 2006-01-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000472-14 A multicenter, randomized, parallel-group, double- blind, placebo-controlled trial to evaluate the efficacy and safety of four different doses of Org 50081 in the treatment of moderate to severe vasom... 2005-12-22 bad-data
Reported results 2004-000487-27 A double-Blind, Parallel-Group, 4-Week Trial to Assess the Efficacy and Safety of Etoricoxib 60 mg and Diclofenac 150 mg in Patients with Chronic Low Back Pain 2005-03-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-000488-83 A Study to Assess Treatment with PEG-Intron® and Rebetol® in Naïve Patients with Genotype 1 Chronic Hepatitis C and Slow Virological Response 2008-05-15 bad-data
Trial is partly outside EEC, and reported results 2004-000558-22 Assessment of the Safety, Efficacy, Tolerability and Pharmacokinetics of PEG-Intron Plus REBETOL for Pediatric Patients with Chronic Hepatitis C 2013-01-10 bad-data
Completed, but no date, and reported results 2004-000612-54 A Multicenter, Randomized, Parallel-Group, Active-Controlled Double-Blind Study Conducted Under In-House Blinding Conditions to Determine the Incidence of Gastroduodenal Ulcers in Patients With Osteoa... bad-data
Reported results 2004-000614-39 A multicenter, randomized, double blind study comparing the clinical effects of intravenous montelukast with palcebo in patients with acute asthma 2007-05-10 due-trials
Reported results 2004-000820-34 Comparison of Three Regimens of PEG-Intron plus Ribavirin in the Treatment of Chronic Hepatitis C, Genotype 2 or 3, in Previously Untreated Patients 2008-03-31 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-000867-92 A Multicenter, Randomized, Double-Blind Study of MK-0431 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control 2006-05-10 bad-data
Ongoing, reported early 2004-000959-42 Avoin, randomis., rinnakkaisryhmillä tehtävä monikeskustutk., jossa tutk. tehoa ja turvallisuutta vertailtaessa lääkityksen vaihtamista rosuvastatiiniin 10 mg päivässä verrattuna atorvastatiiniin 10... not-yet-due
Reported results Terminated 2004-001177-25 Cardiac safety profile of Caelyx therapy in anthracyclin pretreated metastatic breast cancer patients. 2006-08-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-001220-20 Efficacy and safety of PegIntron plus Rebetol in subjects with chronic hepatitis C genotype 1 non responder to Pegasys. 2008-06-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-001376-39 Long-term efficacy and safety evaluation of asenapine (10-20 mg/day) in subjects with schizophrenia or schizoaffective disorder, in a multicenter trial using olanzapine (10-20 mg/day) as a control. 2006-10-06 bad-data
Reported results 2004-001580-22 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to an Ongoing Regimen of Ezetimibe 10 mg in Patients With Homozygous Sitoste... 2005-10-01 due-trials
Reported results 2004-001750-81 A randomized, double-blind, placebo-controlled study to evaluate the persistence of the effect of oral monthly ibandronate on bone resorption in postmenopausal women with osteoporosis 2005-06-13 due-trials
Completed, but no date, and reported results 2004-001883-39 Study to Evaluate the Effect of the Coadministration of SCH 497079 (a Histamine 3 [H3] Receptor Antagonist) Plus Desloratadine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis Who Have ... bad-data
Ongoing, reported early 2004-001907-36 A Phase II Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (L-001079038) in Patients with Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) not-yet-due
Reported results 2004-002156-34 Double-blind, placebo-controlled trial investigating the safety of re-exposure to 900 mg of Org 34517, used as adjunctive therapy in subjects with psychotic major depression (major depressive episode,... 2006-06-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-002159-16 A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 Compared With Sulfonylurea Therapy in Patients With Type 2 Diabetes With Inadequate Glycemi... 2007-06-12 bad-data
Ongoing, reported early 2004-002160-22 A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety of MK-0431 Monotherapy in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency Who Have Inadequate Glycemic Contr... not-yet-due
Completed, but no date, and reported results 2004-002236-26 A Multicenter, Randomized, Parallel-Groups, Double-Blind Placebo Controlled Study Comparing The Efficacy, Safety, And Tolerability Of Co-administration Of Ezetimibe 10 Mg With Ongoing Treatment with S... bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002345-12 An Open-Label, Multicenter Study to Assess the Efficacy of Switching to a Combination tablet Ezetimibe/Simvastatin 10mg/40mg, Compared to Doubling the Dose of Statin in Patients Hospitalized With a Co... 2009-02-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002560-17 A multicenter, double-blind, flexible-dose, 6-month trial comparing the efficacy and safety of asenapina with olanzapine in stable subjects with predominant, persistent negative symptomsof schizophren... 2007-06-20 bad-data
Trial is partly outside EEC, and reported results 2004-002627-40 Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia 2007-06-28 bad-data
Reported results 2004-002930-21 Comparative Study of the Effect of Two Doses of Mometasone Furoate Dry Powder Inhaler 200 mcg and 400 mcg QD PM, Fluticasone Propionate 250 mcg BID, and Montelukast 10 mg QD PM, on Bone Mineral Densit... 2009-11-09 due-trials
Trial is partly outside EEC, and reported results 2004-002945-10 A Study to Evaluate the Efficacy of Quadrivalent HPV (Types 6, 11, 16, and 18) L1 Virus-Like Particle (VLP) in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related Anogenital Warts, and the Inci... 2017-08-22 bad-data
Ongoing, reported early 2004-002988-24 A prospective, multicenter, randomized, double-blind, pilot study to evaluate the safety, the efficacy, the tolerability, and the emergence of resistant gram-negative microorganisms in the bowel in e... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-003000-37 A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination tablets Ezetimibe/Simvastatin 10mg/20mg and Ezetimibe/Simvastatin 10mg/40mg compared to Atorvastatin 20mg in Patients ... 2005-10-26 bad-data
Ongoing, reported early 2004-003807-19 A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-003819-23 A multi-center, randomized, parallel dose-finding, safety-assessor blinded trial to explore the efficacy, safety and pharmacokinetics of four doses of Org 25969 and placebo in pediatric and adult subj... 2006-06-02 bad-data
Completed, but no date, and reported results Terminated 2004-003927-11 A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Continuing Lithium or ValproicAcid/Divalproex Sodium for the Treatment of an... bad-data
Completed, but no date, and reported results Terminated 2004-003989-15 Pegylated Liposomal Doxorubicin (Caleyx) in combination with Herceptin and Taxotere as first-line chemotherapy in metastatic breast cancer patients: A 2 stage Phase II, open label, Multicenter study. bad-data
Completed, but no date, and reported results Terminated 2004-004113-42 SCH 486757 vs Codeine and Placebo in Subjects with Persistent Postviral Cough bad-data
Ongoing, reported early 2004-004302-24 A Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, Safety and Tolerability of L-000883191 in Rheumatoid Arthritis not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-004685-32 A pivotal randomized study of Lonafarnib (SCH 66336) versus placebo in the treatment of subjects with myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) who are platelet transfus... 2008-08-27 bad-data
Trial is partly outside EEC, and reported results 2004-004709-53 A Multicenter, Double-Blind, Randomized, Cross-Over Design Study to Evaluate the Effect of Montelukast vs. Salmeterol on the Inhibition of Excercise-Induced Bronchoconstriction in Asthmatic Patients A... 2008-11-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004771-11 A phase III, randomized, double-blind, active-controlled, non-inferiority clinical trial to investigate the efficacy and safety of a single injection of Org 36286 (corifollitropin alfa) to induce mult... 2018-01-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004772-36 Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 38819 for Org 36286 (corifollitropin alfa) 2009-04-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004773-28 Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 38819 2009-05-07 bad-data
Reported results 2004-004966-34 A Phase III, open-label trial to assess the non-immunogenicity and safety of Org 36286 in patients undergoing repeated controlled ovarian stimulation cycles using either a multiple dose GnRH antagonis... 2009-04-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-004967-30 Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 38825 for Org 36286 (corifollitropin alfa) 2010-01-21 bad-data
Reported results 2004-005023-18 Study in Healthy Young Adults to Assess the Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured by a Process Upgrade 2006-05-10 due-trials
Reported results 2004-005037-19 Multicenter, Double Blind, Randomized, Dose-Ranging, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics, and Antiretroviral Activity of L-000900612 in Combination With an Optimized Back... 2009-07-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-000085-39 An open-label, randomized efficacy and safety study of infliximab versus methotrexate in the treatment of moderate to severe psoriasis. 2008-05-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-000093-50 A Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic C... 2007-02-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-000407-34 A 50 Week Extension to: A Multicenter, Randomized, Double-Blind Factorial Study of the Co-Administration of MK-0431 and Metformin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic... 2008-03-11 bad-data
Ongoing, reported early 2005-000733-37 A randomized, double-blind, placebo-controlled, multicenter parallel-group dose ranging clinical trial to assess the efficacy and safety of Org 4419-2 in the treatment of obstructive sleep apnea/hypop... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-000949-11 A Phase 3, Randomized, Double-blind Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Advanced, Malignant Pleural Mesothelioma Refractory to Systemic Chemotherapy 2012-06-06 bad-data
Ongoing, reported early 2005-001057-21 Vicriviroc in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E1) not-yet-due
Listed as ongoing, but also has a completion date 2005-001058-26 Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E2) 2006-10-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001059-39 A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting with Ac... 2014-10-31 bad-data
Reported results 2005-001133-15 A multi-center, randomized, open-label, prospective bridging, parallel dosefinding trial comparing efficacy, safety and pharmacokinetics of 4 doses of Org 25969 and placebo administered at reappearanc... 2006-03-06 due-trials
Reported results 2005-001134-32 A multi-center, randomized, open-label, prospective bridging, parallel dosefinding trial comparing efficacy and safety of 5 doses of Org 25969 administered at 1-2 PTC after rocuronium or vecuronium in... 2006-04-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-001135-30 A multi-center, randomized, parallel group, comparative, active controlled, safety-assessor blinded, phase IIIa, pivotal trial, in adult subjects comparing Org 25969 with neostigmine as reversal agent... 2006-03-06 bad-data
Reported results 2005-001264-31 Peg-Intron/Rebetol vs Peg-Intron / SCH 503034 with and without Ribavirin in Chronic Hepatitis C HCV 1 Peginterferon alfa/Ribavirin Nonresponders: A SCH 503034 dose finding Phase 2 Study. 2007-06-20 due-trials
Reported results 2005-001472-12 A Phase 3, Placebo-Controlled, Double-Blinded Continuation Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Completing Trial A7501008 and Continuing Lithium or Valproic Acid/Divalproe... 2007-12-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-001511-22 A 24-Month Extension to: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of MK-0822 (Cathepsin-K Inhibitor) in the Treatment of Postmenopausal Wom... 2016-01-20 bad-data
Ongoing, reported early 2005-001792-35 Comparison of rocuronium and Org 25969 with cis-atracurium and neostigmine when neuromuscular block is reversed at reappearance of T2 not-yet-due
Reported results Terminated 2005-001843-49 Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Substudy of P03802 2005-11-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-001889-13 Randomised controlled trial evaluating strategies to optimize disease activity control in RA patients treated with infliximab in clinical practice. 2008-10-29 bad-data
Reported results 2005-001890-83 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Thrombin Receptor Antagon... 2006-09-21 due-trials
Reported results 2005-002000-42 A multi-center, randomized, parallel-group, placebo-controlled, safety-assessor blinded trial, evaluating the safety and efficacy of Org 25969 in cardiac patients 2006-08-01 due-trials
Reported results 2005-002113-21 A Randomized, Double-Blind, Placebo-Controlled, Multicenter 16 Week Study to Assess the Effect of Vitamin D3 8400 IU Once Weekly on Body Sway and Neuromuscular Function in Men and Women Over 70 Years ... 2006-07-18 due-trials
Ongoing, reported early 2005-002118-39 RECAP-DM (Real-life Effectiveness and Care Patterns of Diabetes Management) not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-002169-35 A multicenter, double- blind, flexible-dose, 6-month extension trial comparing the safety and efficacy of asenapine with olanzapine in subjects who completed Protocol 25543 . 2008-01-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002189-12 A randomized, multicenter, international, open-label study of infliximab plus methotrexate versus methotrexate (MTX) alone for the treatment of MTX naïve subjects with Active Psoriatic Arthritis 2008-03-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002364-29 A Two Year Study to Assess the Efficacy, Safety, and Tolerability of L-000899055 in Obese Patients 2008-10-02 bad-data
Reported results 2005-002454-21 A 2-Year Study (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of L-000899055 in Obese Patients 2009-02-10 due-trials
Reported results Terminated 2005-002509-22 A 24-Week, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of MK-0677 for the Treatment of Sarcopenia in Patients Recovering From Hip Fracture 2007-08-22 due-trials
Reported results 2005-002650-22 A Mulitcenter, Randomized, Double-Blind Study Comparing the Clinical Effects of Intravenous Montelukast With Placebo in Pediatric Patients (Ages 6 to 14 Years) With Acute Asthma 2008-04-16 due-trials
Reported results 2005-002926-67 An open-label, randomized, phase IIIB, multicenter trial to evaluate the pharmacodynamic parameters of intubation bolus, and bolus and infusion maintenance doses of Zemuron® in pediatric and adolescen... 2007-07-16 due-trials
Trial is partly outside EEC, and reported results 2005-002928-34 A randomized, assessor-blind, dose-ranging, phase IIIB, multicenter trial comparing the intubating conditions and time course of block of three different intubating doses (0.45 mg/kg, 0.6 mg/kg, and 1... 2007-07-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003035-52 A Double-Blind, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX™ Administered Concomitantly Versus Nonconcomitantly with Influenza Virus Vaccine (Ina... 2006-03-08 bad-data
Reported results 2005-003508-12 Safety and Immunogenicity of Concomitant Use of RotaTeq™ and INFANRIX™ Hexa in Healthy Children 2007-06-14 due-trials
Reported results 2005-003717-33 Open-Label, limited access protocol of Posaconazole in invasive fungal infections. 2007-03-08 due-trials
Ongoing 2005-003749-15 Investigation of the effectiveness of oral lorazepam in managing preoperative dental anxiety in phobic dental patients-A pilot study not-yet-due
Reported results 2005-003869-17 A Multi-center, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Panel Study to Assess the Safety, Tolerability, and Glucose-Lowering Efficacy of MK-0893 in Patients With Type 2 Diabetes Melli... 2007-02-07 due-trials
Completed, but no date Terminated 2005-003876-39 A Randomized, Open-label, Multi-center, Phase 3, 2-arm Study Evaluating the Efficacy and Safety of Peg interferon Alfa-2b Low-dose Maintenance Monotherapy Versus Standard Supportive Care in Patients W... bad-data
Reported results Terminated 2005-004287-23 Safety and Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPD 2008-10-29 due-trials
Reported results Terminated 2005-004289-18 A Multi-centre, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial Investigating Minocycline versus placebo as add-on therapy in patients who are on treatment with Interferon-beta-1a 4... 2011-04-07 due-trials
Reported results 2005-004309-27 Cross-Over Study of the Decongestant Effect of Phenylephrine Compared With Placebo and Pseudoephedrine as Active Control in SAR Subjects Exposed to Pollen in the Vienna Challenge Chamber 2006-02-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-004464-24 A double-blind, placebo-controlled, randomized, parallel-group multicenter study of Mometasone Furoate nasal spray on sleep disturbances and daytime somnolence in subjects with symptomatic seasonal al... 2006-11-07 bad-data
Reported results 2005-004465-41 A multi-center, open-label trial evaluating the Efficacy, Safety and the Impact on Quality of Life of Infliximab Therapy in patients with moderate to severe psoriasis not responding and/or intolerant ... 2009-05-25 due-trials
Reported results 2005-004499-19 A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of L-000796568 in Postmenopausal Women With Overactive Bladder 2006-10-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-004504-36 A multicenter, randomized, double blind, comparative study to evaluate the safety, tolerability, and efficacy of 2 dosing regimens of caspofungin in the treatment of invasive candidiasis in adults 2008-03-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004712-73 A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Dose Finding Study to Determine the Safety and Efficacy of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomitin... 2008-03-20 bad-data
Completed, but no date, and reported results 2005-004848-31 A Multicenter, Randomized, Parallel-Groups, Double-Blind Placebo Controlled Study Comparing The Efficacy, Safety, And Tolerability Of Administration Of Ezetimibe/Simvastatin tablet 10/20 Mg Versus Dou... bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005050-47 A multi-center, parallel-group, comparative trial evaluating the efficacy, pharmacokinetics and safety of Org 25969 in subjects with normal or impaired renal function. 2006-04-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005093-70 A Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Evaluate the Lipid-Altering Efficacy, Safety and Tolerability of MK-0524A in Patients With Primary Hypercholes... 2006-12-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005094-30 A Multicenter, Randomized, Double-Blind, "Factorial" Design Study to Evaluate the Lipid-Altering Efficacy and Safety of MK-0524B Combination Tablet in Patients With Primary Hypercholesterolemia or Mix... 2007-03-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005127-34 A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 in Combination With an Optimized Background Therapy (OBT), Versus Optimi... 2011-04-12 bad-data
Reported results 2005-005146-39 A Phase-2, 12-week, Double-Blind, Dose-Finding, Placebo-Controlled Study to Assess the Efficacy and Safety of a range of SCH 420814 Doses 1 mg BID, 2 mg BID, 5 mg BID and Possibly 10 mg BID in Subje... 2008-11-03 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-005304-16 A randomized, open-label, comparative, multi-center trial to evaluate contraceptive efficacy, cycle control, safety and acceptability of a monophasic COC containing 2.5 mg nomegestrol acetate NOMAC ... 2008-04-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005367-28 A Long-Term Efficacy and Safety Study of Infliximab in the Treatment of Moderate to Severe Plaque-type Psoriasis 2008-11-05 bad-data
Trial is partly outside EEC, and reported results 2005-005449-20 Double blind, randomized, placebo-controlled, parallel-group, multicenter/multinational, efficacy and safety study of desloratadine 5 mg in the treatment of subjects with allergic rhinitis who meet th... 2007-11-08 bad-data
Trial is partly outside EEC, and reported results 2005-005450-45 A double blind, randomized, placebo-controlled, parallel group, multicenter/multinational, efficacy and safety study of desloratadine 5 mg in the treatment of subjects with allergic rhinitis who meet ... 2008-03-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005606-23 A Multicenter, Double-Blind, Randomized, Placebo- and Active-Controlled, Parallel-Group, Dose-Ranging Study of MK-0594 in Patients With Overactive Bladder 2007-12-09 bad-data
Reported results 2005-005910-20 A 12-Week Efficacy and Safety Study of Two Doses of Mometasone Furoate/Formoterol Combination Formulation Compared With Mometasone Furoate Monotherapy, in Persistent Asthmatics Previously treated With... 2008-01-30 due-trials
Exempt, with results 2005-005939-10 A study in healthy, young adults and healthy infants of the safety, tolerability, and immunogenicity of an investigational manufacturing process for the recombinant hepatitis B vaccine 2007-05-10 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-005984-27 A Multicenter, Randomized, Double-Blind, Parallel-Group 6-Month Study to Evaluate the Efficacy and Safety of Oral Montelukast Sodium, Fluticasone Propionate and Placebo in Patients with Chronic Asthma... 2010-04-16 bad-data
Reported results 2005-006048-42 A Phase 2a, Multiple-Dose, Placebo Controlled, Randomized, Two Way Crossover Study to Assess the Efficacy of SCH 420814 in Reducing Anti-Psychotic-Induced Extra-Pyramidal Symptoms Among Subjects With ... 2008-03-06 due-trials
Reported results Terminated 2005-006201-12 A Multicenter, Double-Blind, Randomized, Placebo- and Active-Controlled, Parallel-Group, Dose-Ranging Study of MK-0594 in Patients With Overactive Bladder 2007-09-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000481-37 A randomized, open-label clinical trial to identify predictive factors for controlled ovarian stimulation using a fixed daily dose of 200 IU of recombinant FSH in a GnRH antagonist regimen with or wit... 2008-07-24 bad-data
Ongoing, reported early 2006-000606-23 Post-authorization safety study to check the potential association between the safety profile of beta interferon 1a and the body mass index or pharmacodynamics during the titration phase not-yet-due
Reported results 2006-000676-33 A randomized, open-label, comparative, multi-center trial to evaluate the effects on hemostasis, lipids and carbohydrate metabolism, and on adrenal and thyroid function of a monophasic COC containing ... 2008-01-21 due-trials
Reported results 2006-000764-85 A Open-label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of GARDASIL™ Given Concomitantly with REPEVAX™ in Healthy Adolescents 11-17 Years of Age 2008-02-21 due-trials
Reported results 2006-001335-22 A Multicenter, Double-Blind, Placebo and Active Controlled, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin 100mg Once Daily in Patients with Type 2 Diabetes With I... 2007-03-16 due-trials
Reported results 2006-001392-37 A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metfo... 2007-08-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-001449-33 A study of efficacy, safety, and quality of life (QOL) in patients with chronic idiopathic urticaria dosed with Aerius tablets (5 mg, 10 mg or 20 mg once daily). 2009-04-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001452-12 An open-label, non-controlled multicentre trial to evaluate the insertion characteristics of the radiopaque etonogestrel implant using a next generation applicator 2010-10-20 bad-data
Ongoing, reported early 2006-001546-14 A randomized, open-label, comparative trial to evaluate the effects on ovarian function of a monophasic combined oral contraceptive (COC) containing 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estra... not-yet-due
Reported results 2006-001577-13 A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared With Mometasone Furoate and Formoterol Monotherapy in Subjects with Pe... 2008-08-31 due-trials
Reported results 2006-001578-25 A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared With Mometasone Furoate and Formoterol Monotherapy in Subjects with Pe... 2008-09-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-001579-40 Study of peripheral enthesitis with ultrasonography doppler in spondyloarthropathies treated with infliximab 2008-11-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001637-18 A multicenter,randomized,doubleblind, placebo-controlled study of the effects of KW-3902 injectable emulsion on heart failure signs and symptoms and renal function in subjects with acute heart failure... 2009-07-30 bad-data
Reported results 2006-001638-42 Study to Assess the Safety, Tolerability, and Immunogenicity of 2 Antigen Doses of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process Administered to Healthy Infants at 2, 4, and 6 M... 2007-10-24 due-trials
Ongoing, reported early 2006-001639-23 A Study to Assess the Anamnestic Immune Response 4 to 6 Years After a Primary Vaccination Series With HBVAXPRO™ Estudio para evaluar la respuesta inmune anamnésica 4 a 6 años después de una pauta de v... not-yet-due
Completed, but no date, and reported results Terminated 2006-001761-42 A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of Aprepitant for the Pre... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001913-13 A Worldwide, Double-Blind, Randomized, Placebo-Controlled Study of MK-0524A 2g Coadministered with Intensive LDL-C Lowering Therapy Compared to Intensive LDL-C Lowering Therapy Alone on Carotid Artery... 2008-05-20 bad-data
Reported results Terminated 2006-002090-47 An Efficacy and Tolerability Study of MK-0533 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control 2007-10-24 due-trials
Reported results 2006-002164-26 Study of the Efficacy and Safety of SCH619734 in Subjects with Chronic Idiopathic Cough 2007-10-22 due-trials
Ongoing, reported early 2006-002165-39 Study of the Efficacy and Safety of SCH486757 in Subjects With Chronic Idiopathic Cough not-yet-due
Reported results 2006-002308-32 A Randomized, 26-Week, Placebo-Controlled Efficacy and Safety Study With a 26- Week Long-Term Safety Extension, of High- and Medium-Dose Inhaled Mometasone Furoate/Formoterol Fixed-Dose Combination Fo... 2011-02-28 due-trials
Ongoing, reported early 2006-002309-30 A randomized, 26-Week, Placebo-Controlled Efficacy and Safety Study with a 26-Week Long-Term Safety Extension, of High and Medium Dose Inhaled Mometasone Furoate/Formoterol Fixed-Dose Combination Form... not-yet-due
Reported results 2006-002488-20 Studio Multicentrico randomizzato in doppio cieco per valutare la sicurezza e l'efficacia dell'aggiunta di sitagliptin MK 0431 in pazienti affetti da diabete mellito di tipo 2 in trattamento con metfo... 2008-05-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-002543-92 A safety and efficacy study of SCH 503034 in previously untreated subjects with chronic hepatitis C infected with Genotype 1. 2008-11-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002544-28 A Phase IIb/III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of MK-0364 in Overweight and Obese Patients With Type 2 Diabetes Mellitus (T2DM) 2008-10-02 bad-data
Completed, but no date, and reported results Terminated 2006-002571-40 A randomized, double-blind, active and placebo controlled trial to compare the relative analgesic efficacy and safety of a single intravenous dose of Org 28611 3.0 µg/kg, morphine sulfate 0.12 mg/kg, ... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002669-38 A Phase II Study to Assess the Safety, Tolerability, and Efficacy of MK-0822 (Cathepsin-K Inhibitor) in the Treatment of Women with Breast Cancer and Established Bone Metastases (MBD) 2007-12-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002670-22 Comparación de la eficacia y la seguridad del infliximab, en monoterapia o en combinación con azatioprina, y la azatioprina en monoterapia en la colitis ulcerosa activa de moderada a grave (1.ª parte)... 2010-02-16 bad-data
Trial is partly outside EEC, and reported results 2006-002791-18 A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study Evaluating the Effects of 2 Different Regimens of Montelukast Daily Dosing and Intermittent, Episode-Driven Dosing Compare... 2009-08-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002809-31 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With Acute Coronary Syndrome: Thrombin R... 2011-07-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002942-12 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With a History of Atherosclerotic Diseas... 2011-12-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003080-31 A multi-center, double-blind, flexible-dose efficacy trial with Org 25935 versus placebo as add-on therapy in subjects with predominant, persistent negative symptoms of schizophrenia treated with a st... 2008-10-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003107-39 A Worldwide, Multicenter, Double-Blind, Randomized, Parallel Study to Evaluate the Efficacy of MK-0524 to Improve Tolerability of Extended Release Niacin 2010-08-18 bad-data
Reported results 2006-003109-23 A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK- 0518 Versus Efavirenz in Treatment Naïve HIV-Infected Patients, Each in Combi... 2012-02-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-003169-15 A Phase 2 study of temozolomide (SCH 52365) in Subjects with Advanced Aerodigestive Tract Cancers Selected for Methylation of O6-Methyl-guanine-DNA Methyltransferase (MGMT) Promoter 2009-06-11 bad-data
Completed, but no date, and reported results Terminated 2006-003463-31 COVER- Registro de observación continua tras exposición Vicriviroc (VCV) bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003512-22 A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea... 2008-12-19 bad-data
Ongoing, reported early 2006-003648-46 A Study in Healthy Infants of the Safety, Tolerability, and Immunogenicity of Haemophilus influenzae, Type b/Hepatitis B Vaccine Manufactured With a Modified Process not-yet-due
Reported results 2006-003649-18 A Study in Healthy Adults of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process 2008-02-19 due-trials
Reported results 2006-003650-20 A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured with a Modified Process 2008-05-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-003651-20 A Phase IIb Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (Oka/Merck) in Patients on Chronic/Maintenance Corticosteroids. 2010-08-20 bad-data
Ongoing 2006-003652-37 A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212/Heat-Treated Varicella-Zoster Virus (VZV) ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-003811-36 A phase III, randomized, double-blind, active-controlled, equivalence clinical trial to investigate the efficacy and safety of a single injection of 100 µg Org 36286 (corifollitropin alfa) to induce m... 2007-09-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003812-23 Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 107012 for the development of Org 36286 (corifollitropin alfa) 2008-10-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003813-42 Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 107012 2008-12-12 bad-data
Listed as ongoing, but also has a completion date 2006-003879-12 Compassionate Use of Vorinostat (MK-0683) for the Treatment of Patients with Advanced Cutaneous T-Cell Lymphoma 2012-03-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003881-32 Early Access of MK-0518 in Combination With an Optimized 2010-07-14 bad-data
Reported results Terminated 2006-003924-13 A Phase IIa, Randomized, Double-Blind, Placebo-Controlled, 2-Period Crossover Study to Assess the Efficacy and Safety of MK-0952 in Patients With Alzheimer’s Disease 2007-11-16 due-trials
Reported results 2006-004072-12 A multi-center, randomized, parallel-group, safety assessor-blinded trial comparing efficacy and safety of 4.0 mg.kg-1 Org 25969, administered at T1 3-10% after continuous infusion of rocuronium, and ... 2007-03-02 due-trials
Reported results 2006-004169-33 A 52-Week Efficacy and Safety Non-Inferiority Study of Fluticasone Propionate/Salmeterol 250/50 mcg BID Delivered by Dry Powder Inhaler (DISKUS®) Versus Mometasone Furoate/Formoterol Fumarate 200/10 m... 2008-11-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-004257-14 a multicenter, double blind, placebo and active controlled, parallel group study to compare the efficacy and safety of oral Mk 0974 with placebo and zolmitriptan for the acute treatment of migraine wi... 2007-10-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004259-40 A Multicenter, Double-Blind, Active-Controlled, Parallel Group Study to Examine the Safety, Tolerability and Efficacy of Oral MK-0974 for the Long Term Treatment of Acute Migraine With or Without Aura 2009-01-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004291-12 A MULTI-NATIONAL, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP STUDY TO COMPARE THE SAFETY AND EFFICACY OF 200 mg PAR-101 TAKEN q12h WITH 125 mg VANCOMYCIN TAKEN q6h FOR TEN DAYS IN SUBJECTS... 2009-12-11 bad-data
Reported results Terminated 2006-004366-14 Full title of the trial A Study to Assess the Efficacy and Tolerability of MK-0364 in Maintaining Weight Loss Induced by Diet in Obese Patients 2008-10-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-004534-32 A Phase IIb/III Randomized, Placebo-controlled Clinical Trial to Study the Safety and Efficacy of MK-0364 in Obese Patients and in Overweight Patients with Obesity-related Co-morbidities. 2008-10-02 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004535-30 A Phase II Study of MK-0457 in Patients With BCR-ABL T315I Mutant Chronic Myelogenous Leukemia and Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia 2008-07-31 bad-data
Not reported Terminated 2006-004933-14 A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL™, Tolerability, Immunogenicity, and Efficacy Study of a Second Generation Human Papillomavirus (HPV) L1 V... 2007-02-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-005051-15 A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin (MK-0431) to Patients with Type 2 Diabetes Mellitus Who Have Inadequa... 2008-11-12 bad-data
Reported results 2006-005096-17 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study, Conducted Under In-House blinding Conditions of MK-0633 in Patients With COPD 2009-03-30 due-trials
Completed, but no date, and reported results 2006-005101-64 A Randomized, Placebo-Controlled Study to Evaluate the Safety, Efficacy and Mechanism of Action of MK-0431/Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005122-23 A Phase II/III Randomized, Double-Blind Study of Paclitaxel plus Carboplatin in Combination with Vorinostat (MK-0683) or Placebo in Patients with Stage IIIB (with pleural effusion) or Stage IV Non-Sma... 2008-10-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005234-21 A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid-Dependent Subjects. 2009-05-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005235-14 A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users 2009-12-10 bad-data
Ongoing, reported early 2006-005268-19 Lutropina alfa (Luveris®) en mitad de la fase folicular de la estimulación ovárica controlada (COS) en la edad reproductiva avanzada. Estudio clínico en fase II. not-yet-due
Reported results 2006-005453-30 A Phase 2 Randomized Study Investigating the Safety, Efficacy and Pharmacokinetics of Daptomycin 6 mg/kg and 8 mg/kg Versus Comparator in the Treatment of Subjects Undergoing Surgical Standard of Car... 2010-06-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-005513-35 A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Assess the LDL-C Lowering of Switching to a Combination tablet Ezetimibe/Simvastatin (10mg/20mg) compared to Rosuvastatin 10mg in pa... 2008-03-30 bad-data
Trial is partly outside EEC, and reported results 2006-005515-10 A Multi-center, Open-label, 5-Part Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Aprepitant and Fosaprepitant Dimeglumine in Pediatric Patients Receiving Emetogenic Chemotherapy 2014-02-10 bad-data
Reported results 2006-005585-40 A randomized, parallel group, multiple dose, 6 week study to evaluate safety, tolerability, and pharmacokinetics of asenapine in elderly subjects with psychosis. 2008-12-20 due-trials
Reported results 2006-005592-17 Caelyx® in Breast Cancer in the Elderly 2009-10-16 due-trials
Reported results 2006-005780-26 Ensayo en fase II, multinacional, aleatorizado para evaluar la seguridad de dos pautas de quimioterapia más trastuzumab como terapia adyuvante en pacientes con cáncer de mama HER2-positivo: Caelyx + c... 2010-08-20 due-trials
Reported results 2006-005931-56 A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Initial Therapy With Coadministration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus 2009-01-23 due-trials
Ongoing, reported early 2006-005956-34 A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of MK-0822 in Patients with Osteoarthritis not-yet-due
Ongoing, reported early 2006-006168-46 Thorough QT/QTc study for Garenoxacin not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006187-35 A phase III, Multicenter, Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Oral MK-0974 in the Acute Treatment of Migraine with or Without Aura. 2008-01-11 bad-data
Ongoing 2006-006219-56 A multicentre, double-blind, randomised, parallel-group study to evaluate the efficacy, safety and tolerability of ezetimibe/simvastatin 10/40mg, atorvastatin 40mg, and rosuvastatin 10mg to achieve an... not-yet-due
Trial is partly outside EEC, and reported results 2006-006415-74 A Randomized, Double-Blind, Parallel, Placebo or Amlodipine-Controlled Study of the Effects of Losartan on Proteinuria in Pediatric Patients With or Without Hypertension 2011-03-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006417-32 Vicriviroc en combinación con un régimen TAR optimizado en sujetos infectados por el VIH tratados previamente (VICTOR-E4) 2010-10-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006497-17 "A Multicenter, Randomized, Double-Blind, Parallel Arm, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients with Metabolic Syndrome and Hyperchole... 2008-07-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006529-25 Long-Term Follow-Up of Subjects in a Phase 1, 2, or 3 CLinical Trial in Which Boceprevir or Narlaprevir was Administered for the Treatment of Chronic Hepatitis C 2014-10-13 bad-data
Reported results 2006-006601-83 A Study to Assess the Clinical Effects of SCH 527123 in Psoriasis. 2007-10-31 due-trials
Ongoing, reported early 2006-006686-17 Evaluation of preference for a buprenorphine-based maintenance therapy, after a switch from buprenorphine alone (Subutex®) to the buprenorphine/naloxone combination (Suboxone®), in opioid-dependent pa... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006843-29 A multicentre, randomized, double-blind, placebo controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes in ... 2009-01-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000019-27 A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of Sitagliptin Compared With Metformin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control 2008-08-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000037-19 A Multicenter, Randomized, Double-Blind, Parallel Group, 12 Week Study to Evaluate the Efficacy and Safety of MK-0524B (dosed as coadministered MK-0524A and Simvastatin Tablets) Versus Atorvastatin in... 2010-08-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000145-35 A Phase III, Multicenter, Double-Blind, Randmoized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin Compared With the Addition of Glimepiride in Patients With Type 2 Diabetes M... 2009-10-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000343-10 A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX™ in Subjects ≥60 Years of Age 2009-02-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000344-26 A Phase III Double-Blind, Randomized Multicenter Study to Evaluate the Safety, Tolerability and Immunogenicity of ZOSTAVAX administered comcomitantly versus Non-concomitantly with PNEUMOVAX 23 in subj... 2008-05-12 bad-data
Reported results 2007-000535-26 swiTching from etAnercept to iNfliximab in the treatment of moderate to severe psoriasis; a multi-center, open label trial evaluating the efficacy, tOlerance and safety (TANGO) 2010-10-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-000690-34 A Randomized, Double-Blind, Active Comparator Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan/HCTZ Combination as Compared to Losartan Monotherapy in Pediatric Patients With Ess... 2007-10-22 bad-data
Ongoing, reported early 2007-000755-33 Multicenter, open, pragmatic, randomized trial comparing the efficacy of 3 different lifestyle interventions after addition of sitagliptin to patients with type 2 diabetes mellitus who have inadequate... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-000783-25 A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus KALETRA™ in HIV-Infected Patients Switched from a Stable KALETRA... 2009-04-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001116-22 A Phase II/III Study of MK-0646 Treatment in Combination with Cetuximab and Irinotecan for Patients with Metastatic Colorectal Cancer 2012-03-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001407-37 A multicenter,randomized,doubleblind, placebo-controlled study of the effects of KW-3902 injectable emulsion on heart failure signs and symptoms and renal function in subjects with acute heart failure... 2009-07-25 bad-data
Completed, but no date, and reported results 2007-001611-32 A multi-center cardiac safety study of subjects who participated in Organon sponsored Phase 1 and Phase 2 completed and discontinued trials with Org 24448 (Protocols: 22601;22602;22603; 153001;153002;... bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001691-36 A Multicenter, Double-Blind, Randomized, Placebo and Active Comparator Controlled Dose Range Finding Study in MK-0893 in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control. 2009-03-16 bad-data
Ongoing, reported early 2007-001717-42 A Phase 2, 36 Week, Open-Label, Uncontrolled Safety Follow-Up Study Assessing SCH 420814 5 mg BID not-yet-due
Reported results 2007-001771-11 A Phase I Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Study the Safety, Efficacy, and Mechanism of Action of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitu... 2009-02-24 due-trials
Reported results 2007-001959-19 A 2-Week Double-Blind, Placebo-Controlled, Parallel Group Study Comparing the Anti- Inflammatory Effects of Low, Medium, and High Dose Mometasone Furoate/Formoterol Fumarate MDI Formulation and Medium... 2009-06-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-002017-39 A Multicenter, Randomized, Double-Blind, Parallel Group, 12-Week Study to Evaluate 2008-08-22 bad-data
Reported results 2007-002218-21 A Phase III Randomized, Active-Comparator (Pioglitazone) Controlled Clinical Trial to Study the Efficacy and Safety of Sitagliptin and MK-0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metf... 2010-01-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-002383-95 A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients with Sarcopenia 2009-10-01 bad-data
Reported results 2007-002515-75 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 36-Week Study to Evaluate the Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant in Patients with Type 2 Diabetes Mellitus 2008-08-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-002516-26 A Multicenter, Randomized, Double-Blind, “Crossover” Design Study to Evaluate the Lipid-Altering Efficacy and Safety of MK-0524B Combination Tablet Compared to MK 0524A + Simvastatin Coadministration ... 2008-06-13 bad-data
Reported results 2007-002523-33 A double-blind, randomized, parallel group, placebo-controlled sleep laboratory efficacy and safety study with Org 50081 in elderly subjects with chronic primary insomnia 2009-12-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-002667-28 A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Multiple Attacks Study to Compare the Efficacy and Safety of Oral MK-0974 With Placebo for the Acute Treatment of Migraine With or Witho... 2009-03-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-002693-66 1st extension (MK-0822-018-06, issue date 19-Jun-2013) 2017-02-01 bad-data
Reported results 2007-002911-18 Comparison of the T4/T1 ratio measured by means of the TOF-Watch® SX with the reappearance of T4 measured by means of a peripheral nerve stimulator in adult subjects receiving 4.0 mg.kg-1 sugammadex a... 2008-02-07 due-trials
Reported results Terminated 2007-003133-16 Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects 2010-07-09 due-trials
Reported results 2007-003148-31 A Phase 4 Study of the Pharmacokinetics of Oral Posaconazole Among Patients with Compromised Gastrointestinal Function and at High Risk for Invasive Fungal Infection. 2009-04-24 due-trials
Reported results 2007-003361-40 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Factorial Design Clinical Trial to Study the Efficacy and Safety of MK-0462 / Rizatriptan 10 mg for the Early Treatment of Acute Migraine 2008-04-08 due-trials
Reported results 2007-003428-38 A Phase III Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Prospectively Evaluate Efficacy of Montelukast in Patients Aged 6 Months to 5 Years With Chronic Asthma 2008-02-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-003462-18 A Pivotal Trial to Determine the Efficacy and Safety of AP23573 (Ridaforolimus) when Administered as maintenance Therapy to Patients with Metastatic Soft-Tissue or Bone Sarcomas 2014-09-18 bad-data
Trial is partly outside EEC, and reported results 2007-003528-39 "A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL™, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Multivalent Human Papillomavirus (... 2016-07-08 bad-data
Reported results 2007-003529-26 A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes Mellitus and End-Stage Renal Disease Who Are on Dialy... 2011-03-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-003548-32 A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency Who Have Ina... 2011-03-16 bad-data
Reported results 2007-003636-35 A randomized long-term safety study of Org 50081 in elderly outpatients with chronic primary insomnia examining the effects of 1.5 mg or 3.0 mg of Org 50081 2010-02-19 due-trials
Exempt, with results Terminated 2007-003674-26 A Phase I Dose Escalation of MK-0457 in Combination With Dasatinib in Patients With Refractory Chronic Myelogenous Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. 2008-07-30 not-yet-due
Reported results 2007-003684-41 A Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled Dose-Ranging Study with Active-Controlled Long- Term Safety Phase to Assess the Efficacy, Safety and Tolerability of MK-6213 in... 2009-01-08 due-trials
Reported results 2007-003852-13 A Randomized, Double-Blinded, Tolerability and Immunogenicity Study of a Multivalent Human Papillomavirus (HPV) L1 Virus- Like Particle (VLP) Vaccine (V504) Administered Concomitantly with GARDASIL™ t... 2009-05-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-003971-38 An Observational Follow-Up Study of Pediatric Patients Who Participated in a Previous Respiratory Syncytial Virus (RSV)-Induced Bronchiolitis Study of Montelukast 2011-10-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-004018-15 A Randomized, Multicenter, Double-Blind, Group-Sequential Study to Evaluate the Efficacy, Immunogenicity, and Safety of a Single Dose of Merck 0657nI Staphylococcus aureus Vaccine (V710) in Adult Pati... 2011-08-18 bad-data
Reported results 2007-004020-20 A Phase III Clinical Trial to Evaluate the Efficacy, Immunogenicity, Safety and Tolerability of ZOSTAVAX™ in Subjects 50 to 59 Years of Age 2010-01-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-004043-30 A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of a Single Dose of Intr... 2009-06-29 bad-data
Reported results 2007-004137-42 A Phase III Randomized, Active-Comparator (Pioglitazone) Controlled Clinical Trial to Study the Efficacy and Safety of MK-0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in Patien... 2009-10-23 due-trials
Listed as ongoing, but also has a completion date 2007-004331-27 A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of SCH 900340 5% Solution Compared with Vehicle Administered Topically in the Treatment of Distal ... 2010-02-12 bad-data
Reported results 2007-004448-60 A Multicenter, Randomized, Double-Blind, Parallel Arm, 12-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Elderly Patients With Hyperc... 2009-03-29 due-trials
Trial is partly outside EEC, and reported results 2007-004645-15 Phase 1B Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children With Neutropenia 2015-07-10 bad-data
Reported results 2007-004683-45 An exploratory study of mometasone furoate nasal spray in patients with moderate-severe persistent allergic rhinitis and intermittent asthma: effects on the quality of life evaluated with the Rhinasth... 2009-05-11 due-trials
Reported results 2007-004879-19 A Double-Blind, Placebo-Controlled, Multicenter, Crossover Study to Evaluate the Effects of a Single Oral Dose of Montelukast, Compared With Placebo, on Exercise-Induced Bronchoconstriction (EIB) in P... 2010-03-26 due-trials
Completed, but no date, and reported results Terminated 2007-004980-23 Double-Blind evaluation of the safety and efficacy of Quadriderme cream (betamethasone dipropionate, clotrimazole and gentamicin sulphate ) compare with betamethasone dipropionate combined with gentam... bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005151-42 A PHASE 3 SAFETY AND EFFICACY STUDY IN SUBJECTS WITH CHRONIC HEPATITES C, GENOTYPE 1 WHO FAILED TRIAL TREATMENT WITH PEGINTERFERON/RIBAVIRIN 2010-04-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005236-92 A 6-month, double-blind, randomized, placebo-controlled, parallel group outpatient trial, investigating the efficacy and safety of Org 50081 in adult patients with chronic primary insomnia. 2009-11-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005237-10 A twenty-six weeks, open-label extension trial to evaluate safety and efficacy of Org 50081 in outpatients with chronic primary insomnia who completed clinical trial protocol 21106. 2010-04-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005341-38 A Study to Determine the Activity of SCH 717454 in Subjects With Osteosarcoma or Ewing’s Sarcoma That Has Relapsed After Standard Systemic Therapy 2013-08-31 bad-data
Reported results Terminated 2007-005491-14 TEMOZOLOMIDE IN METASTATIC BREAST CANCER PATIENTS AT HIGH RISK OF BRAIN RECURRENCE: IMPACT ON THE INCIDENCE OF BRAIN METASTASES 2010-06-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005508-42 A Phase 3, Safety and Efficacy Study of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 2010-05-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005615-26 Safety of SCH 527123 in Subjects with Neutrophilic Asthma 2009-02-20 bad-data
Ongoing, reported early 2007-005793-31 A phase II, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Org 3236 tablets in men with Lower Urinary Tract Symptoms (LUTS) suggestive of Benign Prostatic ... not-yet-due
Reported results 2007-005839-28 A 2-year Extension to: A 76-week, Worldwide, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Tolerability and Efficacy of Anacetrapib When Added to Ongoing Therapy With a... 2017-11-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005941-39 An Open Label, Randomized Phase I/IIa Trial Evaluating MK-0646 in Combination With Erlotinib (TARCEVA™) for Patients With Recurrent Non-Small Cell Lung Cancer 2012-02-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-006074-28 A Phase IIa, Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0893 in Combination With Sitagliptin or in Combination With Metfo... 2009-02-04 bad-data
Ongoing, reported early 2007-006097-28 Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of Inhaled Corticosteroid Plus Montelukast Compared with Inhaled Corticosteroid Therapy Alone in Patients with Chronic As... not-yet-due
Reported results 2007-006304-37 A multi-center, randomized, parallel-group, active-controlled, safety-assessor blinded trial, comparing the efficacy and safety of 2.0 mg.kg-1 sugammadex with 50 μg.kg-1 neostigmine administered at re... 2010-09-01 due-trials
Reported results 2007-006934-33 A single center, open-label trial in subjects with severe renal impairment evaluating the dialysability of the sugammadex-rocuronium complex 2009-07-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-006935-29 A multi-center, parallel-group, comparative trial evaluating the efficacy, pharmacokinetics and safety of 4.0 mg.kg-1 sugammadex administered at 1-2 PTC in subjects with normal or severely impaired re... 2010-03-15 bad-data
Reported results 2007-007162-38 A multi-center, open label trial, to show efficacy and safety of 4.0 mg.kg-1 sugammadex administered at a depth of neuromuscular blockade of 1-2 PTC induced by rocuronium in Chinese and European ASA I... 2010-08-25 due-trials
Reported results 2007-007723-40 A Multicenter, Randomized, Double-Blind, Active- and Placebo-Controlled, Period Crossover Study to Evaluate the Safety and Efficacy of MK-0974 in the Treatment of Acute Migraine in Patients With Stabl... 2009-09-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-007951-14 A multi-center, randomized, parallel-group, comparative, active-controlled, safety-assessor blinded trial in adult subjects comparing the efficacy and safety of sugammadex administered at 1-2 PTC with... 2009-05-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000149-72 A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-7009 Administered Concomitantly With Pegylated-Interferon and Ribavirin for 28 Days in Treatment-Naïve Patient... 2010-04-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000150-12 A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety and Tolerability of MK-7009 When Administered Concomitantly With Pegylated Interferon and Ribavirin in Patients With Chronic Hepa... 2012-09-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000422-39 A Phase IIA Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide with or without Deforolimus in Men with Asymptomatic, Metastatic Castrate-Resis... 2011-05-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000454-12 A Study of Dose Optimization of Infliximab in the Treatment of Moderate to Severe Plaque Psoriasis. 2011-04-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000465-37 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study to Evaluate the Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy... 2008-07-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000634-53 A randomized phase II trial of deforolimus (AP23573; MK-8669) compared to progestin in female adult patients with advanced endometrial carcinoma following one line of chemotherapy 2012-07-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000982-51 Infliximab as First Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial 2011-11-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-001153-17 Phase III (Phase V Program), Open-Label, Randomized, Referred- Care-Controlled, Clinical Trial to Evaluate the Efficacy and Safety of MK-0217A/Alendronate Sodium 70 mg/Vitamin D3 5600 I.U. Combination... 2010-07-20 bad-data
Reported results 2008-001226-14 A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Dose-Finding Study of MK-3207 in the Treatment of Acute Migraine 2009-01-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-001971-30 A Phase II Trial of Oral Deforolimus (AP23573; MK-8669), an mTOR Inhibitor, in Combination with Trastuzumab for Patients with HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer 2011-05-10 bad-data
Reported results Terminated 2008-002079-28 A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0724 Intravenous Infusion on the Amelioration of Neurological Damage and... 2008-11-06 due-trials
Completed, but no date, and reported results Terminated 2008-002119-42 A Phase III Study to Assess the Tolerability and Efficacy of MK-0822 (Odanacatib) in Reducing the Risk of Bone Metastases and Prolonging Disease-Free Survival in Women with Breast Cancer bad-data
Reported results Terminated 2008-002120-29 A Phase III Study to Assess the Safety, Tolerability, and Efficacy of MK-0822 (Odanacatib) in Prolonging Bone Metastasis-Free Survival in Men with Castration-Resistant Prostate Cancer 2010-01-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-002121-36 A 104-Week Extension to: A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequa... 2010-06-25 bad-data
Exempt, with results 2008-002142-38 A phase I, single center, open-label parallel group trial to compare the pharmacokinetics of NOMAC between healthy female adolescents (aged 14-17 years) and healthy female adults (aged 18-50 years) af... 2009-05-18 not-yet-due
Reported results Terminated 2008-002209-38 A multicenter, randomized, double-blind, placebo-controlled study of the hemodynamic effects of rolofylline injectable emulsion in the treatment of patients with heart failure 2009-03-06 due-trials
Reported results 2008-002518-23 A randomized, safety-assessor blinded trial comparing 4.0 mg.kg-1 sugammadex with placebo in adult subjects scheduled for surgery requiring profound neuromuscular blockade 2009-06-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-002733-70 A Phase III Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of Once Daily Raltegravir (MK-0518)Versus Twice Daily Raltegravir, Each ... 2011-05-16 bad-data
Trial is partly outside EEC, and reported results 2008-003178-17 A Multicenter, 2-Part Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Aprepitant in Pediatric Patients Undergoing Surgery. 2013-03-12 bad-data
Reported results 2008-003377-41 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial, with Placebo Run-In, and an Open-Label Treatment Period, to Evaluate the Performance of the Cogstate Computerized Neu... 2010-04-14 due-trials
Reported results 2008-003379-28 A Phase III Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Multiple-Dose, Clinical Trial to Study the Safety and Efficacy of MK-0663/Etoricoxib and Ibuprofen in the Treatment of ... 2010-12-14 due-trials
Reported results 2008-003640-11 A Multicenter, Randomized, Double-Blind Study of the Co-Administration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control 2011-03-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-003752-30 An International, Multicenter, Randomized, Double-Blind, Study of Vorinostat (MK-0683) or Placebo in Combination with Bortezomib in Patients Multiple Myeloma 2015-06-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-003753-33 An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination with Bortezomib in Patients with Relapsed and Refractory Multiple Myeloma 2012-04-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-003780-38 A 2-Year, Dose Range-Finding, Adaptive-Design Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPD 2011-11-11 bad-data
Ongoing, reported early 2008-003864-20 A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long-Term Safety of Ragweed (Ambrosia artemisiifolia) Sublingual Tablet (SCH 39641) in Adu... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-003923-21 A Phase III, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of MK-0826/Ertapenem and Meropenem in Patients with Complicated Urinary Tract Infections 2009-06-08 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004095-43 A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK-0974 Co-administered with Ibuprofen or Acetaminophen in Patie... 2009-08-24 bad-data
Not reported Terminated 2008-004119-36 Proof-of-Concept and Dose Range-Finding Study of SCH 527123 in Subjects with Severe Asthma 2010-01-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004504-31 A Phase III Randomized, Placebo-Controlled Study to Evaluate the Effect of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Overall Safety, and to Estimate the Effect of Odanacatib (MK-0822) on ... 2011-03-21 bad-data
Reported results 2008-004555-30 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Lipid-Modifying Effect and Tolerability of MK-1903 in Patients with Dyslipidemia 2009-09-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004556-71 A Single-Arm Study to Provide Boceprevir Treatment in Subjects with Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin in Previous Schering-Plough Boceprevir Studies. 2012-12-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004578-42 An Imaging Sub-Study of the Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopau... 2014-11-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004686-26 A Phase II Multicenter, Randomized, Double-Blind, Two-Stage Clinical Trial to Evaluate the Efficacy and Safety of MK-0594 in Patients with Alcohol Dependence 2010-03-11 bad-data
Trial is partly outside EEC, and reported results 2008-004732-20 A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK-0954/Losartan Potassium in Pediatric Patients With Hypertension 2012-08-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004760-39 A phase 3 safety and efficacy study of boceprevir in combination with peginterferon alfa-2a and ribavirin in subjects with chronic hepatitis C genotype 1 who failed prior treatment with peginterferon/... 2010-10-19 bad-data
Reported results Terminated 2008-004831-39 A Worldwide, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of MK-0736 When Added to Ongoing Therapy With Angiotensin-... 2010-05-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004864-38 A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected with HIV and Hepatitis C 2012-10-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004867-21 A Double-Blind, Placebo-Controlled, Multicenter Trial to Study the Efficacy and Tolerability of MK-0663/Etoricoxib in the Treatment of Pain after Abdominal Hysterectomy 2010-07-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004881-16 Efecto de la acadesina sobre los eventos adversos cardiovasculares y cerebrovasculares, clínicamente significativos, en pacientes de alto riesgo que se someten a cirugía de derivación aortocoronaria ... 2010-10-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004953-14 A Multicenter, Randomized, Double-Blind, Titration Study to Evaluate and Compare the Efficacy and Safety of Ezetimibe 10 mg Added on to Rosuvastatin 5 mg, 10 mg, 20 mg, or 40 mg Versus Up-Titration Ro... 2010-05-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005002-40 A Randomized, Double-Blind, Active-Controlled, Multicenter Study of Patients with Primary Hypercholesterolemia and High Cardiovascular Risk and not Adequately Controlled with Atorvastatin 20 mg: A Com... 2010-09-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005061-57 A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Dose- Ranging Study of MK-0633 in Adult Patients with Chronic Asthma 2009-05-11 bad-data
Reported results 2008-005318-35 A prospective, double-blind, placebo-controlled trial investigating the efficacy and safety of Org 25935 in relapse prevention in subjects with alcohol dependence 2010-06-25 due-trials
Reported results 2008-005616-40 A Phase IIa, Multicenter, Double-Blind, Randomized, Active-Controlled, Parallel-Arm Clinical Trial to Study the Efficacy and Safety of MK-0941 Compared to Sulfonylurea in Patients with Type 2 Diabetes... 2010-03-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005817-23 A Phase IIA, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-8245 in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control 2009-08-20 bad-data
Ongoing, reported early 2008-005874-11 A Substudy to Explore Biomarkers of Physical Function in the Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fra... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-005942-22 A Randomized Discontinuation Phase II Trial of Deforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients with KRAS Mutations 2012-08-29 bad-data
Completed, but no date, and reported results Terminated 2008-006018-97 A Phase IIb, Multicenter, Randomized, Double-Blind Placebo-Controlled, 2-period adaptive Crossover Polysomnography Study to Evaluate the Safety and Efficacy of MK-4305 in Patients With Primary Insomni... bad-data
Listed as ongoing, but also has a completion date and reported results 2008-006215-20 A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of MK-0941 in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Insulin 2010-05-26 bad-data
Trial is partly outside EEC, and reported results 2008-006271-70 A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Efficacy and Safety Study of Ezetimibe Monotherapy in Children (Ages 6 to 10 Years) With Primary Hypercholesterolemia (Heterozygous Fam... 2012-04-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-006719-20 TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control 2015-03-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-006720-62 A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin (MK-0431) in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glyc... 2010-11-11 bad-data
Reported results 2008-007504-28 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the 2015-01-29 due-trials
Reported results 2008-007689-52 A Randomized, Double-Blind, Active-Controlled, Multicenter Study of Patients with Cardiovascular Disease and Diabetes Mellitus Not Adequately Controlled with Simvastatin 20 mg or Atorvastatin 10 mg: A... 2011-03-02 due-trials
Reported results 2008-008006-46 A Randomized Clinical Trial to Evaluate the Effects of High Dose Statin and Niacin Therapy on Excised Plaque Biomarkers in Patients Undergoing Carotid Endarterectomy (CEA) 2010-10-22 due-trials
Reported results 2008-008257-30 A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Overall Safety in the Treatment of Osteoporosis in Pos... 2011-09-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-008283-26 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg ODT for the Treatment of Acute Migraine in Patients on Topira... 2009-10-22 bad-data
Reported results 2008-008354-23 CONSERV TM – 2 (Clinical Outcomes and Safety Trial to Investigate Ecallantide’s Effect on Reducing Surgical Blood Loss Volume) – A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects E... 2010-05-31 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-009517-18 A Phase IIa, Multicenter, Randomized, Placebo- and Active- Comparator Controlled, Cross-Over Clinical Trial to Study the Safety and Efficacy of MK-3577 in Patients with Type 2 Diabetes Mellitus Who Ha... 2010-07-12 bad-data
Not reported 2009-010108-27 A Six-week Evaluator-Blind, Randomized, Active-Controlled 2012-11-20 due-trials
Trial is partly outside EEC, and reported results 2009-010110-30 A phase III, randomized, active-controlled, parallel-group clinical trial to study the efficacy and long-term safety of mometasone furoate / formoterol fumarate (MF/F, MK-0887A [SCH418131]), compared ... 2017-12-04 bad-data
Reported results Terminated 2009-010904-27 A Phase II Randomized, Open-Label, Multiple-Rising Dose Clinical Trial to Study the Efficacy and Safety of MK-2578 for the Maintenance of Anemia Treatment in Patients With Chronic Kidney Disease Wh... 2010-05-26 due-trials
Exempt, with results 2009-011101-16 Dose-Escalation Study to Evaluate the Safety and Tolerability of SCH 717454 in Combination with Different Treatment Regimens in Subjects with Advanced Solid Tumors (Phase 1b/2; Protocol No. P04722) 2010-03-03 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-011137-26 An open-label study assessing the addition of subcutaneous golimumab (GLM) to conventional disease-modifying antirheumatic drug (DMARD) therapy in biologic-naïve subjects with rheumatoid arthritis (Pa... 2012-02-02 bad-data
Listed as ongoing, but also has a completion date 2009-011617-25 A Phase III Clinical Trial to Study the Immunogenicity, Tolerability, and Manufacturing Consistency of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered in Pre... 2013-05-02 bad-data
Ongoing 2009-011920-69 A Quantitative Computed Tomography (QCT) Sub-Study of the Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fractu... not-yet-due
Reported results Terminated 2009-012000-10 A Phase II Randomised, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK 7009 when administered concomitantly with Pegylated Interferon and Ribavi... 2010-09-08 due-trials
Reported results 2009-012121-11 A randomized, multicenter, explorative trial to explore the safety, acceptability and vaginal bleeding pattern of three doses of an etonogestrel-releasing medicated intrauterine system (ENG-MIUS) vers... 2011-07-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012772-27 A Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Extended-Release (ER) Niacin and Laropiprant (ERN/... 2011-01-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012782-63 Boceprevir and Peginterferon/Ribavirin for the Treatment of Chronic Hepatitis C in Treatment-Naive Subjects: A Comparison of Erythropoietin Versus Ribavirin Dose Reduction for the Management of Anem... 2011-10-26 bad-data
Reported results Terminated 2009-012926-35 A Phase IIb, Randomized, Placebo-Controlled, Dose-Ranging Study of MK-5442 in the Treatment of Postmenopausal Women with Osteoporosis 2010-10-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-013053-15 A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa-2a and Ribavirin to Patients with Chronic Hepatitis C Infection after Participation in Other MK-7009 Cl... 2013-05-29 bad-data
Reported results Terminated 2009-013286-26 A Phase IIb, Randomized, Active Comparator-Controlled, Open-Label Clinical Trial to Study the Efficacy and Safety of MK-2578 for the Treatment of Anemia in ESA (Erythropoiesis-Stimulating Agent)-Naive... 2010-06-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-013552-72 A Phase 3, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Dose-Range-Finding Efficacy and Safety Study of Preladenant in Subjects With Early Parkinson’s Disease (Phase 3 Protocol No. P0566... 2013-05-23 bad-data
Completed, but no date, and reported results 2009-014657-32 "A Phase IIa Randomized, Placebo-Controlled, Parallel Group, Clinical Trial to Study the Efficacy and Safety of MK-2866 in Women with Moderate to Severe Chronic Obstructive Pulmonary Disease Participa... bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014729-18 "A Phase IIb, Randomized, Double-Blind, Placebo- and Active-Controlled, Dose-Range-Finding Study to Evaluate the Effects of MK-5442 on Bone Mineral Density (BMD) in the Treatment of Osteoporosis in Po... 2011-06-16 bad-data
Exempt, with results 2009-015103-58 A Multicenter, Double-Blind Study of the Safety, Tolerability, and Immunogenicity of Pneumococcal Conjugate Vaccine (V114) Compared to Prevnar™ in Healthy Adults and Toddlers 2011-01-05 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-015161-31 A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety Study of Preladenant in Subjects With Moderate to Severe Parkinson’s Disease (Phase 3; Protocol No. P... 2012-12-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-015162-57 A Phase 3, 40-week. Active-controlled, Double-blind, Double-Dummy Extension Study of Preladenant in Subjects with moderate to severe Parkinson`s Disease. 2013-05-23 bad-data
Reported results 2009-015247-16 A Randomized, Double-Blind, Active-Controlled, Multicenter Study of Patients with Primary Hypercholesterolemia and High Cardiovascular Risk Who Are Not Adequately Controlled with Atorvastatin 10 mg: A... 2012-10-18 due-trials
Reported results 2009-015500-26 "A Phase III Randomized, International, Placebo-Controlled, Double-Blind Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Par... 2015-11-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-015565-31 A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Long Term Safety Study of MK-4305 in Patients with Primary Insomnia 2011-08-01 bad-data
Reported results 2009-015773-12 A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 2-Period Adaptive Crossover Polysomnography Study to Evaluate the Safety and Efficacy of MK 6096 in Patients with Primary Insomn... 2011-02-01 due-trials
Reported results 2009-015798-11 “Ensayo de fase III, aleatorizado, controlado con un fármaco de comparación activo, con doble enmascaramiento, de doce semanas de duración, para comparar la eficacia y la seguridad de MK-2452 (0,0015%... 2010-09-17 due-trials
Reported results 2009-016070-33 A Phase IIa, Randomized, Double-Blind, Placebo- and Active- Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of MK-6913 for the Treatment of Vasomotor Symptoms in Postmenopausal Wom... 2010-08-24 due-trials
Reported results 2009-016218-26 A Phase III Open-Label Clinical Trial to Study the Immunogenicity and Tolerability of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, Given Concomitantly With REPE... 2011-06-16 due-trials
Trial is partly outside EEC, and reported results 2009-016374-32 A Worldwide, Randomized, Double Blind, Placebo-Controlled, Parallel Group Clinical Trial to Evaluate the Safety and Efficacy of Rizatriptan for the Acute Treatment of Migraine in Children and Adolesce... 2011-05-06 bad-data
Trial is partly outside EEC, and reported results 2009-016375-30 A Worldwide, Open Label, Clinical Trial to Examine the Long Term Safety and Tolerability of Rizatriptan in Pediatric Migraineurs for the Treatment of Migraine With or Without Aura 2011-04-29 bad-data
Reported results Terminated 2009-016376-76 A Phase II Extension of a Randomized, Open-Label, Multiple-Rising Dose Clinical Trial to Study the Efficacy and Safety of MK-2578 for the Maintenance of Anemia Treatment in Patients with Chronic Kidne... 2010-04-01 due-trials
Completed, but no date, and reported results Terminated 2009-016587-36 Artritis de cadera asociada a la EA. Eficacia y Seguridad del tratamiento precoz con Infliximab (Remicade®) bad-data
Exempt, with results 2009-017054-12 A Two Part, Phase I-IIa Study Evaluating MK-1775 in Combination With Topotecan/Cisplatin in Adult Patients With Cervical Cancer not-yet-due
Reported results 2009-017272-24 Randomized, Double-Blinded, Placebo-Controlled, Parallel-Design, Dose-Range Finding Study of Subcutaneous SCH 900222 in Subjects with Moderate-to-Severe Chronic Plaque Psoriasis 2012-10-24 due-trials
Completed, but no date Terminated 2009-017288-40 A Randomized, Open-Label, Comparative, Multicenter Trial to Compare the Effects on Metabolic Parameters of Two NOMAC-E2 Batches (Pivotal Phase III and Commercial Batch) and a Monophasic COC Containing... bad-data
Trial is partly outside EEC, and reported results 2009-017971-10 An 8-week, placebo-controlled, double-blind, randomized, fixed-dose efficacy and safety trial of asenapine in adolescent subjects with schizophrenia bad-data
Trial is partly outside EEC, and reported results 2009-018038-12 A 26-week, multi-center, open-label, flexible dose, long-term safety trial of asenapine in adolescent subjects with schizophrenia bad-data
Reported results 2010-018318-62 A Phase III, Randomized, Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on a Sulfonylu... 2012-01-19 due-trials
Reported results 2010-018407-28 A Multicenter, Randomized, Double-Blind, Fixed-Dose, 6-Week Trial 2014-09-09 due-trials
Reported results 2010-018408-96 A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial 2015-03-06 due-trials
Reported results 2010-018409-13 A Phase 3b, Multicenter, Double-Blind, Fixed-Dose, Parallel-Group, 2014-05-28 due-trials
Reported results 2010-018410-78 A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed with Bipolar 1 Disorder who Completed Protocol P05691 (formerly 041044) (Phase3B, Pr... 2014-11-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-018413-30 A Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Parallel Group, Study to Evaluate the Safety and Efficacy of MK-4305 in Patients with Primary Insomnia- Study A 2011-12-07 bad-data
Reported results 2010-018414-69 A Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK-4305 in Patients with Primary Insomnia- Study B 2011-11-08 due-trials
Reported results 2010-019288-13 A Six Month Phase II/III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Telcagepant (MK-0974) for Prevention of Menstrually Related ... 2011-04-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-019454-41 A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) in the treatment of Men with Osteoporosis Treated with Vitamin D and Calcium 2013-07-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019775-29 A Multicenter, Double-Blind Study of the Safety, Tolerability, and Immunogenicity of Pneumococcal Conjugate Vaccine (V114) Compared to Prevnar 13™ in Healthy Infants 2012-07-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019867-13 A Randomized Trial of Ridaforolimus in Combination with Dalotuzumab Compared to Exemestane in Estrogen Receptor Positive Breast Cancer Patients 2013-10-15 bad-data
Reported results 2010-019871-31 A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK- 0663/Etoricoxib in Patients with R... 2014-08-07 due-trials
Reported results 2010-019872-65 A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patients... 2014-11-12 due-trials
Reported results 2010-020112-11 A Phase 3, 12-Week, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Preladenant in Subjects with Moderate to Severe Parkinson’s Disease. (Phase 3; Protocol No. P07037) 2013-04-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-020150-34 A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety,Tolerability, Efficacy, and Immunogenecity of V212 in Recipients of Autologous Hematopoietic C... 2015-12-23 bad-data
Reported results 2010-020234-26 A Phase III, Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Patients With Type 2 Diabetes Mellit... 2012-10-31 due-trials
Exempt, with results 2010-020832-20 An Evaluation of the Safety and Pharmacokinetics of Posaconazole (POS, SCH 56592) IV Solution via Peripheral Administration in Healthy Volunteers (P06356) not-yet-due
Reported results 2010-021367-32 A Randomized, Open-Label, Dose-Finding Trial of Polyethylene Glycol 3350 Laxative Plus Electrolytes for the Treatment of Constipation 2011-11-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-021627-27 A Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled 12-Week Study to Evaluate the Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lip... 2013-01-11 bad-data
Reported results 2010-022121-15 A 52-week Extension to: A Phase IIb Randomized, Placebo- and Active Comparator (Tolterodine)-Controlled, 2-Part Clinical Study of the Efficacy and Safety of MK-4618 in Patients with Overactive Bladder 2013-10-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-022168-11 A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of 6-Day Oral TR-701 Free Acid and 10-Day Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Stru... 2011-09-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-022193-13 A 66 week extension to: A Phase IIb, Randomized, Placebo-Controlled, Dose-Range Finding Clinical Trial to Study the Safety and Efficacy of MK-3102 in Patients with Type 2 Diabetes Mellitus and Inadequ... 2013-04-01 bad-data
Trial is outside EEC, and reported results 2010-022647-38 Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated with Bipolar I Disorder (Protocol No. P06107) bad-data
Trial is outside EEC, and reported results 2010-022648-19 A 26-Week Open-Label, Flexible-Dose Trial of Asenapine Extension Treatment to P06107 in Pediatric Acute Manic or Mixed episodes Associated With Bipolar I Disorder bad-data
Listed as ongoing, but also has a completion date and reported results 2010-023156-89 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy 2017-04-11 bad-data
Reported results 2010-023452-87 A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PHASE 3 STUDY TO COMPARE THE SAFETY AND EFFICACY OF INTRAVENOUS CXA 201 AND INTRAVENOUS LEVOFLOXACIN IN COMPLICATED URINARY TRACT INFECTION, INCLUDING PYELONEP... 2013-09-04 due-trials
Reported results 2010-023453-11 A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PHASE 3 STUDY TO COMPARE THE SAFETY AND EFFICACY OF INTRAVENOUS CXA 201 AND INTRAVENOUS LEVOFLOXACIN IN COMPLICATED URINARY TRACT INFECTION, INCLUDING PYELONEP... 2013-05-29 due-trials
Trial is partly outside EEC, and reported results 2010-023498-20 Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects with Chronic Hepatitis C Genotype 1 (Phase 1b) 2014-01-21 bad-data
Completed, but no date, and reported results 2010-023580-18 Ensayo clínico fase II, de cetuximab en cáncer colorrectal metastático refractario con K-RAS mutado y genotipos FcyRII/IIIa favorables Phase II clinical study of cetuximab in refractory colorectal can... bad-data
Reported results 2010-023759-27 A Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing the Efficacy and Safety of a Sitagliptin-Based Treatment Paradigm to a Liraglutide-Based Treatment Paradigm in Patients With T... 2012-04-30 due-trials
Reported results 2010-023939-42 A Phase III Multicenter, Double-Blind, Crossover Design Study to Evaluate Lipid-Altering Efficacy and Safety of Extended-Release Niacin/Laropiprant/Simvastatin Combination Tablet in Patients with Prim... 2011-11-14 due-trials
Not reported Terminated 2010-024260-17 A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Paediatric Subjects With Chronic Hepatitis C Genotype 1 2014-01-21 due-trials
Reported results 2011-000311-34 A Multicenter, Randomized, Double-blind, Placebo-controlled Study of 2015-01-28 due-trials
Trial is partly outside EEC, and reported results 2011-000651-16 A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial, Conducted Under In-House Blinding Conditions, to Examine the Efficacy and Safety of Aprepitant for the Prevention of... 2013-08-16 bad-data
Reported results 2011-000656-42 A 66-Week Extension to: A Phase IIb, Randomized, Placebo-Controlled, Dose-Range Finding, Clinical Trial to Study the Safety and Efficacy of MK-3102 in Patients with Type 2 Diabetes Mellitus and Inadeq... 2013-04-01 due-trials
Trial is partly outside EEC, and reported results 2011-000729-55 A Phase I Study of Ridaforolimus in Paediatric Patients with Advanced Solid Tumours 2018-05-25 bad-data
Reported results 2011-000759-18 A Randomized, Active-Controlled Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly with Peginterferon alf... 2015-03-10 due-trials
Reported results Terminated 2011-001007-12 A Phase III Multicenter, Double-Blind, Crossover Design Study to Evaluate Lipid-Altering Efficacy and Safety of 1 g/10 mg Extended-Release Niacin/Laropiprant/Simvastatin Combination Tablets in Patient... 2011-11-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-001201-27 A randomized, controlled, parallel-group, double-blind trial of sugammadex or usual care (neostigmine or spontaneous recovery) for reversal of rocuronium- or vecuronium-induced neuromuscular blockade ... 2012-09-26 bad-data
Reported results 2011-001345-32 A Phase 3, Safety and Efficacy Study of Boceprevir/Peginterferon Alfa-2a/ribavirin in Chronic HCV Genotype 1 IL28B CC Subjects 2015-06-08 due-trials
Reported results 2011-002119-27 A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PHASE 3 STUDY TO 2013-09-10 due-trials
Reported results 2011-002120-41 A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PHASE 3 STUDY TO 2013-10-15 due-trials
Trial is partly outside EEC, and reported results 2011-002142-13 A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate/Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Ado... 2016-10-11 bad-data
Reported results 2011-002313-11 A Phase II Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Immunogenicity of V212 in Adult Patients with Autoimmune Disease 2013-02-26 due-trials
Trial is outside EEC, and reported results 2011-002348-28 A Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety, Tolerability, and Single-Dose Pharmacokinetics of MK-0462 in Migraineurs Aged 6 to 17 Years bad-data
Trial is outside EEC, and reported results 2011-002349-36 An Open-Label Single-Dose Study to Evaluate the Pediatric Palatability of Maxalt Oral Disintegrating Tablets bad-data
Completed, but no date 2011-002508-34 Evaluate adherence to treatment with Glucophage sachets versus tablets in diabetes type 2 patients, previously treated with metformin tablets bad-data
Trial is partly outside EEC 2011-002528-42 A Phase III, Multicenter, Double-Blind, Randomized, Placebo- and Metformin-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Sitagliptin in Pediatric Patients with Type 2 Diabetes Melli... bad-data
Ongoing 2011-002529-23 A Phase III, Multicenter, Double-Blind, Randomized, Placebo -Controlled Clinical Trial to Evaluate the Safety and Efficacy MK-0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in P... not-yet-due
Reported results 2011-002533-18 52 Week Extension: A Phase IIb Randomized, Placebo- and Active Comparator (Tolterodine)-Controlled, 2013-10-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002803-13 A Randomised, Phase II Study Evaluating MK-1775 in Combination with Paclitaxel and Carboplatin versus Paclitaxel and Carboplatin Alone in Adult Patients with Platinum Sensitive p53 Mutant Ovarian Canc... 2016-08-05 bad-data
Reported results 2011-002860-26 A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing 2013-01-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-003151-20 A Randomised, Placebo-Controlled, Parellel-Group, Double-Blind Efficacy and Safety Trial of MK-8931 with a long term double-blind extension in Subjects with Mild to Moderate Alzheimer's Disease 2017-04-14 bad-data
Reported results Terminated 2011-003299-36 A Randomized, Partially Double-Blind, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomita... 2012-05-01 due-trials
Reported results Terminated 2011-003399-36 A Phase III Randomized, Double-Blind, Active-Controlled Clinical Trial to Study the Efficacy and Safety of MK-4214 (filgrastim) and Neupogen™ as an Adjunct to Combination Chemotherapy with Doxorubicin... 2012-01-26 due-trials
Exempt, with results 2011-003407-38 A Phase I Study of Monotherapy Dalotuzumab and Ridaforolimus-Dalotuzumab Combination Treatment in Paediatric Patients with Advanced Solid Tumours not-yet-due
Trial is outside EEC, and reported results 2011-003433-33 A Single Dose Biocomparison Study to Assess two Pediatric Formulations of MK-8669 to the Provisional Market Formulation in Healthy Subjects bad-data
Reported results Terminated 2011-003600-20 A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Co-Administration of Sitagliptin and Atorvastatin in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Contr... 2012-12-04 due-trials
Ongoing 2011-003938-14 A Phase 3 Randomized Study of the Efficacy and Safety of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults and Adolescents (Phase 3; Protocol No. MK- not-yet-due
Reported results 2011-003971-12 A Phase III Clinical Trial to Study the Safety and Efficacy of MK-1293 Compared to Lantus? in Subjects With Type 1 Diabetes Mellitus. 2015-11-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-004525-27 A 1-Year, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Anacetrapib When Added to Ongoing Statin Therapy With or Witho... 2018-11-13 bad-data
Reported results 2011-004542-18 A Multicenter, Double-Blind Study of the Safety, Tolerability, and 2013-02-15 due-trials
Reported results 2011-004590-90 A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-3415 (Human Monoclonal Antibody to Clostridium dif... 2015-01-19 due-trials
Reported results 2011-004622-96 A Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes ... 2013-06-07 due-trials
Reported results 2011-004994-94 A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of a Single Infusion of MK-6072 (Human Monoclonal Antibody to C. difficile toxin B), and MK-341... 2015-05-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-005186-20 A Phase 3 Study to Evaluate the Efficacy and Safety of Dinaciclib or Ofatumumab in Subjects with Refractory Chronic Lymphocytic Leukemia (CLL) 2014-12-22 bad-data
Reported results 2011-005200-15 A Phase IIa, Multicenter, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 for Treatment Augmentation in Patients with Major Depressive Disorder. 2013-09-03 due-trials
Reported results Terminated 2011-005514-10 A 2nd Open-Label Extension for 5 Years to: The Placebo-Controlled 1st Extension to a Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce t... 2017-02-01 due-trials
Reported results 2011-005686-20 A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to 2014-08-12 due-trials
Reported results 2011-005707-32 A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients with C... 2015-07-28 due-trials
Trial is partly outside EEC, and reported results 2011-006006-27 A Phase IIb, Partially-Blinded, Randomized, Active Comparator-Controlled Study to Evaluate the Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Aprepitant in Pediatric Patients for the 2016-09-26 bad-data
Reported results 2012-000252-34 A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients with Clostridium Difficile Associated Diarrhea 2015-03-20 due-trials
Reported results 2012-000317-36 A Phase IIA Open Label, Adaptive, Randomized Clinical Trial of Dalotuzumab (MK-0646) Treatment in Combination with Irinotecan Versus Cetuximab and Irinotecan for Patients with Metastatic Rectal Cancer... 2014-12-09 due-trials
Reported results 2012-000335-11 A Phase 2 Randomized Trial of the Combination of Ridaforolimus 2018-03-15 due-trials
Reported results 2012-000439-17 A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Worldwide, Dose-Ranging Clinical Trial with a Proof-of-Concept Lead Cohort to Evaluate the Safety, Tolerability, ... 2013-09-13 due-trials
Reported results 2012-000642-35 A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects with Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast 2014-05-05 due-trials
Reported results Terminated 2012-000643-27 A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Adaptive-Design, Dose-Ranging Study of MK-1029 in Adult Subjects with Persistent Asthma 2014-07-30 due-trials
Completed, but no date Terminated 2012-000972-40 A Multicentered, Randomized, Open-Label, Pragmatic Use Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation. bad-data
Trial is partly outside EEC, and reported results 2012-001258-25 A phase III, multi-center, open label, uncontrolled trial to investigate the efficacy and safety of MK-8962 (corifollitropin alfa) in combination with human Chorionic Gonadotropin (hCG) in inducing in... 2015-04-08 bad-data
Ongoing 2012-001377-88 A 52-Week, Phase 3, Randomized, Active Comparator and Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222 / MK-3222, Followed by an Op... not-yet-due
Trial is partly outside EEC, and reported results 2012-001443-49 A Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ER Niacin/Laropiprant in Adolescents with Heterozygous Familial Hypercholesterolemia 2013-01-11 bad-data
Reported results 2012-001573-93 Multicenter, Double-Blind, Randomized, 2-Part, Dose Ranging Study to Compare the Safety, and Antiretroviral Activity of MK-1439 Plus TRUVADA™ Versus Efavirenz Plus TRUVADA™ in Antiretroviral Treatment... 2016-03-18 due-trials
Reported results 2012-001611-23 A Double-Blind, Randomized, COntrolled, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of a New Formulation of RotaTeq(TM) 2014-03-25 due-trials
Reported results 2012-001718-41 A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Efficacy and Safety of a Single 150 mg Dose of In... 2014-11-03 due-trials
Reported results 2012-001855-38 A Phase IIb, Randomized, Placebo-Controlled, Dose-Finding Clinical Trial to Study the Safety and Efficacy of MK-8237 using an Environmental Exposure Chamber in Subjects with House Dust induced Allergi... 2013-08-27 due-trials
Reported results 2012-001868-29 A Phase III, Randomized, Double-Blind, Clinical Trial to Study the Efficacy and Safety of MK-0431D (a fixed-dose combination [FDC] of sitagliptin and simvastatin) for the Treatment of Patients With Ty... 2013-11-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-001886-33 Randomized, Controlled, Parallel Group, Double Blind Trial to Compare the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures Using a 2x2 Factori... 2014-04-29 bad-data
Reported results 2012-002181-12 A Phase IIa, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Worldwide, Proof-of-Concept Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Subj... 2013-10-08 due-trials
Ongoing 2012-002232-85 A Long-Term Follow-up Study to Evaluate the Durability of Virologic Response and/or Viral Resistance Patterns of Subjects With Chronic Hepatitis C Who Have Been Previously Treated with MK-5172 in a Pr... not-yet-due
Reported results 2012-002309-23 A Phase III, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK-3102 Compared With the Addition of Glimepiride in Patients With Type 2 Diabetes Melli... 2015-01-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002332-85 A Phase III, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of MK-3102 Versus Placebo in Subjects with Type 2 Diabetes Mellitus with Moderate or Severe Chronic Kidney ... 2016-01-19 bad-data
Trial is partly outside EEC, and reported results 2012-002340-24 A Phase IIb, Partially-Blinded Randomized, Active Comparator-Controlled Study to Evaluate the Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Fosaprepitant in Pediatric Patients for the... 2016-11-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-002414-39 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus 2017-03-22 bad-data
Reported results Terminated 2012-002434-37 A Worldwide, Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week Study to Assess the Efficacy and Tolerability of Anacetrapib When Added to Ongoing Lipid-Lowering Therapy in Adult Patie... 2014-02-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002449-40 A multicenter, randomized, partially blinded, placebo-controlled clinical trial to evaluate the effect on primary dysmenorrheal of vaginal rings with an average daily release of 700 µg nomegestrol ac... 2013-09-23 bad-data
Reported results 2012-002458-21 Open-label, Phase 4 Study, investigating the Incidence of Extra-Articular Manifestations in Subjects with Ankylosing Spondylitis treated with Golimumab 2015-04-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002459-41 A multicenter, randomized, partially-blinded, Phase IIb dose-finding study on ovarian function, vaginal bleeding pattern, and pharmacokinetics associated with the use of combined vaginal rings releasi... 2013-10-15 bad-data
Reported results 2012-002612-10 A Phase III, Multicenter, Randomized, Double-Blind, Placebo Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of MK-3102 to Subjects With Type 2 Diabetes Mellitus Who Have Ina... 2014-12-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002758-22 A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-... 2014-08-04 bad-data
Ongoing, reported early 2012-002771-33 An open label study assessing SVR and Viral Resistance profile with Boceprevir plus PEG-IFN plus Ribavirin triple therapy in HCV-1 infected patients with insulin resistance who have failed PEG-IFN plu... not-yet-due
Reported results 2012-002772-13 A multi-centre single-arm study to evaluate the efficacy and safety of BOCEPREVIR 44 weeks in addition to standard of care (SOC) in previously treatment failure (relapser, non-responders, both partial... 2015-11-17 due-trials
Completed, reported early 2012-002862-11 A Prospective, Randomized, Double-Blind, Multicenter, Phase 3 2018-06-06 not-yet-due
Trial is partly outside EEC, and reported results 2012-003030-17 Randomized, Phase II Study of MK-3475 versus Chemotherapy in Patients with Advanced Melanoma 2019-01-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-003110-14 A 24-Week, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Anacetrapib When Added to Ongoing Statin Therapy With or With... 2014-10-29 bad-data
Reported results Terminated 2012-003140-68 A Pharmacokinetic Analysis of Posaconazole in the Plasma and Alveolar Compartment of Lung Transplant Recipients 2014-01-17 due-trials
Reported results 2012-003333-42 A Phase II Randomized, Dose Ranging, Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Different Doses of MK-5172 When Administered Concomitantly with Peginterferon alfa-2b and Riba... 2014-02-26 due-trials
Other 2012-003340-72 A Phase II Randomized Clinical Trial to Study the Efficacy and Safety of MK-5172 in Combination with Ribavirin (RBV) in Subjects with Chronic Hepatitis C Virus Infection not-yet-due
Reported results 2012-003354-89 A Phase II Randomized Clinical Trial to Study the Efficacy and Safety of the combination regimen of MK-5172 and MK-8742 +/-Ribavirin (RBV) in Subjects with Chronic Hepatitis C Virus Infection 2015-06-01 due-trials
Trial is partly outside EEC, and reported results 2012-003414-14 A Single-Dose Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Odanacatib in Adolescents and Young Adults Treated with Glucocorticoids 2016-07-14 bad-data
Trial is partly outside EEC, and reported results 2012-003447-29 A COMPARATIVE EVALUATION OF THE SAFETY AND EFFICACY OF DAPTOMYCIN VERSUS STANDARD OF CARE IN PEDIATRIC SUBJECTS ONE -SEVENTEEN YEARS OF AGE WITH BACTEREMIA CAUSED BY STAPHYLOCOCCUS AUREUS. 2016-01-20 bad-data
Reported results 2012-003626-24 A Multicenter, Phase III, Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of MK-3102 Monotherapy in Subjects with Type 2 Diabetes Mellitus and Inadequate Glycemic Control 2015-06-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-003670-11 A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of MK-3102 to Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Contr... 2016-03-16 bad-data
Trial is partly outside EEC 2012-004035-23 A Phase III Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-0431A XR (a Fixed-Dose Combination Tablet of Sitagliptin and Extended-Rel... bad-data
Completed, but no date, and reported results Terminated 2012-004190-12 Randomized, Double-blind, Multicenter Study to Evaluate the Efficacy and Safety of MK-8808 versus MabThera™ in Patients with Advanced CD20-Positive Follicular Lymphoma. bad-data
Ongoing, reported early 2012-004303-12 A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-3102 in ≥18 and <45 Year-Old Subjects with Type 2 Diabetes Mellitus and Inadequat... not-yet-due
Ongoing 2012-004391-19 A Phase II/III Randomized Trial of Two Doses of MK-3475 (SCH900475) versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer not-yet-due
Ongoing 2012-004907-10 A Multicenter, Randomized, Controlled, Three-Arm, Phase III Study to Evaluate the Safety and Efficacy of Two Dosing Schedules of MK-3475 Compared to Ipilimumab in Patients with Advanced Melanoma not-yet-due
Not reported Terminated 2012-005170-65 A Phase IIa Open Label, Randomized Clinical Trial to Study the Safety and Efficacy of Vintafolide and the Combination of Vintafolide and Paclitaxel Compared to Paclitaxel in Subjects with Advanced Tri... 2014-06-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-005542-38 A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects with Amnestic Mild Cognitive Impairment Du... 2018-04-17 bad-data
Reported results 2013-000059-42 A Phase III, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK-3102 Compared with the Addition of Sitagliptin in Subjects with Type 2 Diabetes Melli... 2014-11-17 due-trials
Reported results 2013-000161-36 Phase 2 Proof-of-Activity Study of Oral Posaconazole in the Treatment of Asymptomatic Chronic Chagas Disease (Phase 2, Protocol No. P05267) 2015-01-12 due-trials
Reported results 2013-000301-23 A Phase III, Multicenter, Double-Blind, Randomized Trial to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Subjects With Type 2 Diabetes Mellitus For Whom Metformin is Inappr... 2014-04-03 due-trials
Trial is partly outside EEC, and reported results 2013-000864-28 A Multicenter, Randomized, Double-Blinded Comparative Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daptomycin Versus Active Comparator in Pediatric Subjects With Acute Hematogenous ... 2016-12-20 bad-data
Trial is partly outside EEC, and reported results 2013-001314-15 A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of a 2-dose regimen of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, administered in Prea... 2017-07-24 bad-data
Trial is outside EEC, and reported results 2013-001448-75 A Phase 2A, Multi-Center, Open-Label, Uncontrolled Study to bad-data
Reported results 2013-001526-26 An Observational Follow-Up Study for: A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic... 2016-07-23 due-trials
Reported results Terminated 2013-001637-40 Switching from regimens consisting of a RTV -boosted protease inhibitor plus TDF/ FTC to a combination of RAltegravir pluis NevIrapine and IAmivudine in HIV patients with suppressed viremia and and i... 2017-07-10 due-trials
Completed, but no date, and reported results Terminated 2013-001740-54 A 28-Week, Phase 3, Randomized, Active Comparator and bad-data
Reported results 2013-001939-47 A Phase III Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Reformulated Raltegravir 1200 mg Once Daily Versus Raltegravir 4... 2016-12-19 due-trials
Trial is partly outside EEC, and reported results 2013-002084-26 A Multicenter, Double-Blind, Randomized, Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive C... bad-data
Reported results 2013-002169-21 A Phase II Clinical Trial to evaluate the Efficacy and Safety of a combination regimen of MK 5172 with/without MK 8742 and/or Ribavirin (RBV) in Subjects with Chronic Hepatitis C Genotypes 2, 4, 5 and... 2014-12-04 due-trials
Ongoing 2013-002518-11 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLI... not-yet-due
Ongoing, reported early 2013-002519-90 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 26-Week Multicenter Study with a 26-Week Extension to Evaluate the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Subject... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2013-003290-95 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 26-Week Multicenter Study With a 78-Week Extension to Evaluate The Efficacy and Safety of Ertugliflozin in Subjects With Type 2 Diabetes Mellit... 2017-08-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-003582-34 A Phase III, Multicenter, Randomized, Double-Blind, Active-Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Ertugliflozin (MK-8835/PF-04971729) Compared With th... 2017-04-18 bad-data
Reported results 2013-003587-31 A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) in Subjects with Type 2 Diabetes Mellit... 2016-09-28 due-trials
Reported results 2013-003697-26 A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of Ertugliflozin (MK-8835/PF-04971729) in the Treatment of Sub... 2016-06-06 due-trials
Reported results 2013-003698-82 A Phase III, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Ertugliflozin (MK-8835/PF-04971729) with Sitagliptin Compared with Ertugliflozin Alon... 2016-06-06 due-trials
Reported results 2013-003831-31 A Phase III Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-8228 (Letermovir) for the Prevention of Clinically Significant Human Cytomegalovirus (CMV) Infection... 2016-11-21 due-trials
Reported results 2013-003858-25 A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects with Chronic Hepatitis C Virus Infection and Chronic Kidney Dise... 2015-09-02 due-trials
Listed as ongoing, but also has a completion date 2013-004154-22 A Phase 3 Randomised Double-Blind Study Comparing TR-701FA and Linezolid in Ventilated Gram-Positive Nosocomial Pneumonia 2018-06-22 bad-data
Reported results 2013-004213-41 A Phase II Clinical Trial to Study the Efficacy and Safety of the combination regimen of MK-5172 + MK-8742 + Ribavirin (R) in Subjects with Chronic Hepatitis C Virus Infection who failed prior Direct ... 2015-05-04 due-trials
Completed, but no date Terminated 2013-004423-36 Randomized, parallel group, controlled trial to compare two different “NMB + reversal” strategies in adult obese patients underwent laparoscopic abdominal surgery (Phase 4; Protocol No. MK-8616-104-00... bad-data
Reported results 2013-004583-56 Golimumab: A Phase 4, UK Open Label, Single arm Study on its Utilization and Impact in Ulcerative Colitis 2016-05-25 due-trials
Reported results 2014-000137-22 A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects with Chronic HCV GT1, GT4 and GT6 Infection 2015-09-06 due-trials
Ongoing 2014-000323-25 A Randomized Open-Label Phase III Trial of MK-3475 versus Platinum based Chemotherapy in 1L Subjects with PD-L1 Strong Metastatic Non-Small Cell Lung Cancer not-yet-due
Reported results 2014-000342-30 A Phase III Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who ... 2015-05-22 due-trials
Listed as ongoing, but also has a completion date 2014-000343-32 A Phase III Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who a... 2018-12-04 bad-data
Ongoing, reported early 2014-000656-29 Preference for a prefilled syringe or Smartject™ device for delivering SIMPONI (golimumab) in patients suffering from moderate to severe ulcerative colitis not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-000672-25 A Phase II/III Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects with Chronic Hepatitis C Virus Infection with Advanced Cirrhosis... 2015-06-16 bad-data
Reported results 2014-000824-12 A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Subjects who have Failed Prior Treatment with Pegylated Interferon and Ribavirin... 2015-06-19 due-trials
Completed, but no date, and reported results Terminated 2014-001030-29 A Phase III, Double-blind, Lot-to-Lot Consistency Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of V212 in Healthy Adults bad-data
Reported results 2014-001049-25 A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Initial Combination of Ertugliflozin (MK-8835/PF-049717... 2016-02-23 due-trials
Ongoing 2014-001127-69 A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg Once ... not-yet-due
Ongoing 2014-001473-14 A Randomized, Open Label, Phase III Study of Overall Survival Comparing Pembrolizumab (MK-3475) versus Platinum Based Chemotherapy in Treatment Naïve Subjects with PD-L1 Positive Advanced or Metastati... not-yet-due
Ongoing, reported early 2014-001749-26 A Phase III Randomized Trial of MK-3475 (Pembrolizumab) versus Standard Treatment in Subjects with Recurrent or Metastatic Head and Neck Cancer not-yet-due
Trial is partly outside EEC, and reported results 2014-001783-34 A Phase III, Randomised, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0517/Fosaprepitant and Ondansetron Versus Ondansetron for the Prevention of Chemotherapy-Induced Nause... 2017-02-24 bad-data
Ongoing 2014-002009-40 A Phase III Randomized Clinical Trial of Pembrolizumab (MK-3475) versus Paclitaxel, Docetaxel or Vinflunine in Subjects with Recurrent or Progressive Metastatic Urothelial Cancer not-yet-due
Ongoing 2014-002206-20 A Phase II Clinical Trial of Pembrolizumab (MK-3475) in Subjects with Advanced/Unresectable or Metastatic Urothelial Cancer not-yet-due
Reported results 2014-002208-26 A Phase 3, randomized, active-comparator controlled clinical trial to study the contraceptive efficacy and safety of the MK-8342B (etonogestrel + 17?-estradiol) vaginal ring and the levonorgestrel-eth... 2016-10-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-002356-27 A Phase III Double Blind Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects with Chronic HCV GT1, GT4 and GT6 Infection with Inherited Blood ... 2016-06-14 bad-data
Ongoing 2014-002447-18 A Phase II Clinical Trial of Single Agent Pembrolizumab (MK-3475) in Subjects with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Who Have Failed Platinum and Cetuximab not-yet-due
Ongoing 2014-002587-33 An Open-Label 5-Year 2nd Extension to: A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporoti... not-yet-due
Trial is partly outside EEC, and reported results 2014-002807-10 A Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous (IV) and Powder for Oral Suspension Formulations of Posaconazole (POS) in Immunocompromised Pediatric Subjects with Neutropenia 2018-09-30 bad-data
Trial is partly outside EEC 2014-002950-38 A Phase I/II Study of Pembrolizumab (MK-3475) in Children with advanced melanoma or a PD-L1 positive advanced, relapsed or refractory solid tumor or lymphoma (KEYNOTE-051) bad-data
Reported results 2014-003262-25 An open label, single group assignment design study to correlate soluble ST2 with clinical, endoscopic and histological activity in moderate to severe Ulcerative Colitis patients under golimumab 2017-09-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-003304-73 A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT1 and... 2016-12-06 bad-data
Reported results 2014-003347-35 A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT3, GT... 2017-05-03 due-trials
Ongoing 2014-003382-17 A Phase III Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-1439A Once-Daily Versus ATRIPLA™ Once-Daily in Treatment-Naïve ... not-yet-due
Trial is outside EEC, and reported results 2014-003485-24 A Phase 1, Non-comparative, Open-label Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of Ceftolozane/tazobactam in Pediatric Patients Receiving Standard of Care Antibiotic The... bad-data
Ongoing 2014-003574-16 A Phase II Clinical Trial of Pembrolizumab as Monotherapy and in Combination with Cisplatin+5-Fluorouracil in Subjects with Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma ... not-yet-due
Ongoing 2014-003583-20 A 34-week Follow-up to: A Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy MK-0431A (A Fixed-Dose Combination Tablet of Sitaglipt... not-yet-due
Ongoing 2014-003698-41 A Phase 3 Clinical Trial of Pembrolizumab (MK-3475) in First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. not-yet-due
Reported results 2014-003836-38 A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR Pr... 2016-02-16 due-trials
Trial is partly outside EEC, and reported results 2014-004023-40 PHASE 3 STUDY OF IV TO ORAL 6-DAY TEDIZOLID PHOSPHATE COMPARED WITH 10-DAY COMPARATOR IN SUBJECTS 2018-09-17 bad-data
Ongoing 2014-004026-17 A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Subjects with High Risk Non-muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BC... not-yet-due
Trial is partly outside EEC, and reported results 2014-004341-27 A Phase III, Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-3641, a Ragweed (Ambrosia artemisiifolia) Sublingual Immunotherapy Tablet, in Children With a History ... 2018-11-19 bad-data
Trial is outside EEC, and reported results 2014-004350-34 A Comparative Bioavailability Study of a Tablet versus an Investigational bad-data
Ongoing 2014-004482-24 A Phase II clinical trial of MK-3475 (pembrolizumab) in subjects with relapsed or refractory (R/R) classical Hodgkin Lymphoma (cHL) not-yet-due
Trial is outside EEC, and reported results 2014-004581-16 An Immunogenicity and Safety Study of GARDASIL™ in Chinese Female Subjects Aged 9 to 45 Years and Male Subjects Aged 9 to 15 Years bad-data
Trial is outside EEC, and reported results 2014-004582-24 A Randomized, Evaluator-Blind, Crossover, Single Dose Study of the Bronchodilator Effect of Formoterol Fumarate in Combination With Mometasone Furoate Metered Dose Inhaler Delivered With and Without a... bad-data
Trial is outside EEC, and reported results 2014-004583-38 An Open-Label Study to Assess the Safety and Tolerability of Zenhale® (a Fixed-Dose Combination of Mometasone Furoate/Formoterol Fumarate Delivered by Metered Dose Inhaler) in 40 Subjects with Persist... bad-data
Trial is outside EEC, and reported results 2014-004603-78 A Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of Aprepitant for the Prevention o... bad-data
Trial is outside EEC, and reported results 2014-004748-37 Korean Study of “Real-world” Montelukast Use in Mild Asthmatic Children with Concomitant Allergic Rhinitis bad-data
Trial is outside EEC, and reported results 2014-004749-28 MK-476 Phase III Open Label Exploratory Comparative Study -Acute Exacerbations of Asthma- bad-data
Trial is outside EEC, and reported results 2014-004766-15 MK-518B Food Effect Study bad-data
Trial is outside EEC, and reported results 2014-004767-21 MK-0518B (EU Sourced Lamivudine) Bioequivalence Study bad-data
Trial is outside EEC, and reported results 2014-004774-42 A Phase III, Double-Blind, Randomized, Placebo-Controlled Cross-over Clinical Trial to Study the Efficacy and Safety of MK-0476 in Japanese Pediatric Subjects with Seasonal Allergic Rhinitis. bad-data
Trial is outside EEC, and reported results 2014-004776-27 A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Bronchodilatory Effect of MK-0476 in Patients with Chronic Asthma bad-data
Trial is outside EEC, and reported results 2014-004871-22 A Phase III, Open-Label Clinical Trial to Study the Safety and Pharmacokinetics of MK-0476 in Japanese Pediatric Subjects Aged 1 to 15 Years Old with Perennial Allergic Rhinitis bad-data
Trial is outside EEC, and reported results 2014-004875-21 Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Protocol No. P05067) bad-data
Trial is outside EEC, and reported results 2014-004910-27 A Multicenter, Noncomparative, Open-label Study to Estimate the Safety, Efficacy, and Pharmacokinetics bad-data
Trial is outside EEC, and reported results 2014-004911-35 A Multicenter, Open-Label, Noncomparative Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Acetate in Children with Documented Candida or Aspergillus Infections bad-data
Trial is outside EEC, and reported results 2014-004916-12 Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Protocol No. P05106). bad-data
Trial is outside EEC, and reported results 2014-004917-10 A Double-Blind Placebo-Controlled, Randomized, Parallel-Group, Multicenter Clinical Trial To Evaluate Efficacy And Safety Of Mometasone Furoate Nasal Spray In Children With Adenoid Hypertrophy. SNORE ... bad-data
Trial is outside EEC, and reported results 2014-004918-28 PLACEBO-CONTROLLED STUDY OF MOMETASONE FUROATE NASAL bad-data
Trial is outside EEC, and reported results 2014-004919-36 PLACEBO-CONTROLLED STUDY OF MOMETASONE FUROATE NASAL SPRAY (MFNS) 200 MCG QD IN THE RELIEF OF NASAL CONGESTION ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS (SAR) bad-data
Trial is outside EEC, and reported results 2014-004920-23 PLACEBO-CONTROLLED STUDY OF MOMETASONE FUROATE NASAL SPRAY (MFNS) 200 MCG QD IN THE RELIEF OF NASAL CONGESTION ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS (SAR) (Protocol No. P05583) bad-data
Trial is outside EEC, and reported results 2014-004921-41 Multicenter, double-blind, randomized, placebo-controlled study of mometasone furoate nasal spray in pediatric subjects with perennial allergic rhinitis bad-data
Trial is outside EEC, and reported results 2014-004922-16 A study of long-term (12-24 weeks) administration of mometasone furoate nasal spray in pediatric subjects with perennial allergic rhinitis (Protocol No. P06333) bad-data
Trial is outside EEC, and reported results 2014-004923-40 Double blind, placebo controlled trial, evaluating the role of Nasonex® in the management of nasal obstruction secondary to adenoids hypertrophy in children. bad-data
Trial is outside EEC, and reported results 2014-004924-23 Efficacy and Safety of Concurrent Administration of Mometasone Furoate Nasal Spray (MFNS) and Oxymetazoline Nasal Spray Administered Once Daily (QD) vs. Oxymetazoline Twice Daily (BID), Mometasone Fu... bad-data
Trial is outside EEC, and reported results 2014-004925-42 Efficacy and Safety of 200 mcg BID Mometasone Furoate Nasal Spray (MFNS) vs Placebo as Adjunctive Treatment to Antibiotics in Relief of Symptoms of Acute Bacterial Sinusitis bad-data
Trial is outside EEC, and reported results 2014-004926-17 OPEN LABEL, 12-WEEK CLINICAL TRIAL TO ASSESS EFFICACY, SAFETY, TREATMENT ADHERENCE AND QUALITY OF LIFE IMPACT ON MOMETASONE FUROATE DRY POWDER 400 MCG ONCE DAILY IN PERSISTENT MILD-MODERATE ASTHMATIC ... bad-data
Ongoing 2014-004944-37 Adjuvant immunotherapy with anti-PD-1 monoclonal antibody Pembrolizumab (MK-3475) versus placebo after complete resection of high-risk Stage III melanoma: A randomized, double-blind Phase 3 trial of t... not-yet-due
Trial is outside EEC, and reported results 2014-004993-40 A Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Sitagliptin in Adolescents bad-data
Trial is outside EEC, and reported results 2014-005021-13 A Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Versus (Amphotericin B) Liposome for Injection as Empirical Therapy in Pedi... bad-data
Trial is outside EEC, and reported results 2014-005030-54 A Multicenter, Open, Sequential Dose-Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of 2 Separate Doses of Caspofungin Acetate in Children Between the Ages of 3 to 24 M... bad-data
Trial is outside EEC, and reported results 2014-005032-34 A Multicenter, Sequential-Panel, Open-Label, Noncomparative Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Caspofungin Acetate in Neonates and Infants Less Than 3 Months of Age bad-data
Ongoing 2014-005241-45 A Phase III, Randomized, Open-label Clinical Trial of Pembrolizumab (MK-3475) versus Paclitaxel in Subjects with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma who Progressed after First... not-yet-due
Reported results 2014-005525-13 A Phase III, Multicenter, Randomized, Double-Blind, Active-Comparator Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin Compared with the Addition of Dapagliflo... 2017-10-10 due-trials
Ongoing 2014-005550-18 A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and Tw... not-yet-due
Trial is outside EEC, and reported results 2014-005717-23 A Long Term Immunogenicity, Safety, and Effectiveness Study of GARDASIL™ (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) Among Adolescents Who Received GARDASIL™ at 9-18 Years of Age bad-data
Trial is partly outside EEC, and reported results 2015-000066-62 A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Estimate the Efficacy and Safety of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipe... 2017-09-18 bad-data
Listed as ongoing, but also has a completion date 2015-000246-34 A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazo... 2019-04-03 bad-data
Ongoing 2015-000294-13 A Phase II Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy for Metastatic Triple-Negative Breast Cancer (mTNBC) – (KEYNOTE-086) not-yet-due
Ongoing 2015-000575-27 A randomized, phase 3 trial with anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) versus placebo for patients with early stage NSCLC after resection and completion of standard adjuvant therapy (P... not-yet-due
Exempt 2015-000681-55 A Phase I/II Study to Assess the Safety and Efficacy of MK-3475 in Combination with Trametinib and Dabrafenib in Subjects with Advanced Melanoma not-yet-due
Ongoing 2015-000972-88 A Randomized, Active-Controlled, Partially Blinded, Biomarker Select, Phase III Clinical Trial of Pembrolizumab as Monotherapy and in Combination with Cisplatin+5-Fluorouracil versus Placebo+Cisplatin... not-yet-due
Ongoing 2015-001020-27 A Randomized Open-Label Phase III Study of Single Agent Pembrolizumab versus Single Agent Chemotherapy per Physician’s Choice for Metastatic Triple Negative Breast Cancer (mTNBC) – (KEYNOTE-119) not-yet-due
Reported results 2015-001483-19 A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (MK-5172 + MK-3682 + MK-8408 Fixed Dose Combination (FDC)) in Subjects with Ch... 2017-09-25 due-trials
Trial is outside EEC, and reported results 2015-001656-29 A Phase III, Open-Label Clinical Trial to Study the Safety and Immunogenicity of V110 in Subjects 50 Years of Age and Older and in Subjects 2 to 49 Years of Age at Increased Risk for Pneumococcal Dise... bad-data
Reported results 2015-001658-14 A Phase III, Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Immunogenicity of Three Consistency Lot Doses and a High Dose of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adult... 2017-09-29 due-trials
Ongoing 2015-001852-32 A Phase II Study of Pembrolizumab (MK-3475) as Monotherapy in Subjects with Previously Treated Locally Advanced Unresectable or Metastatic (Stage IV) Mismatched Repair Deficient or Microsatellite Inst... not-yet-due
Trial is partly outside EEC 2015-001878-18 A Phase III, Multi-Center, Open Label, Single-Group Trial to Investigate the Efficacy and Safety of MK-8962 (corifollitropin alfa) in Combination with human Chorionic Gonadotropin (hCG) for Initiation... bad-data
Ongoing 2015-002024-89 A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (KEYNOTE-177) not-yet-due
Ongoing 2015-002067-41 A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE 158) not-yet-due
Not reported 2015-002134-49 A Parallel-Group, Double-Blind, Long Term Safety and Efficacy Trial of MK-8931 (SCH 900931) in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD). 2018-04-17 due-trials
Trial is outside EEC, and reported results 2015-002237-22 A Study to Compare the Pharmacokinetics of a Fixed-Dose Combination of Raltegravir and Lamivudine to Co-administered Raltegravir and Lamivudine bad-data
Ongoing 2015-002406-37 A Phase 2 Study of Pembrolizumab (MK 3475) in Subjects with Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) not-yet-due
Ongoing 2015-002427-26 A Phase II Study of Pembrolizumab Monotherapy in Third-line Previously Treated Subjects with Advanced/Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus or Advanced/Metastatic Siewe... not-yet-due
Ongoing 2015-002509-13 A phase III study of Pomalidomide and low dose Dexamethasone with or without Pembrolizumab (MK3475) in refractory or relapsed and refractory Multiple Myeloma (rrMM) (KEYNOTE 183) not-yet-due
Trial is outside EEC, and reported results 2015-002778-19 An Evaluation of the Safety, Efficacy and Pharmacokinetics of Daptomycin in Pediatric Subjects Aged One to Seventeen Years With Complicated Skin and Skin Structure Infections Caused by Gram-Positive P... bad-data
Trial is outside EEC, and reported results 2015-002779-64 An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged 3 Months to Twenty-Four Months Who Are Concurrently Receiving Standard Antibiotic Ther... bad-data
Trial is outside EEC, and reported results 2015-002780-42 A Phase 1, Open-Label, Multi-Center, Two-Part, Single-Dose, Parallel Design, Safety, Tolerance, and bad-data
Trial is outside EEC, and reported results 2015-002781-23 An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged Two to Six Years Who are Concurrently Receiving Standard Antibiotic Therapy for Proven... bad-data
Ongoing 2015-002782-32 A Phase III Randomized Open-label Study of Single Agent Pembrolizumab vs Physicians' Choice of Single Agent Docetaxel, Paclitaxel, or Irinotecan in Subjects with Advanced/Metastatic Adenocarcinoma and... not-yet-due
Ongoing 2015-002901-12 A phase III study of Lenalidomide and low-dose Dexamethasone with or without Pembrolizumab (MK3475) in newly diagnosed and treatment naïve Multiple Myeloma (KEYNOTE 185). not-yet-due
Trial is outside EEC, and reported results 2015-002931-16 A Phase III Placebo-controlled Clinical Trial to Study the Tolerability, Immunogenicity and Efficacy of V501 in 16- to 26-year-old Japanese men bad-data
Trial is outside EEC, and reported results 2015-002932-42 A Phase IV Open-label, Descriptive Study to Evaluate the Safety and Effectiveness on the Incidence of HPV 6, 11, 16 and 18 Related CIN 2/3 or worse of the Quadrivalent HPV (Types 6, 11, 16, 18) L1 Vir... bad-data
Trial is partly outside EEC 2015-003006-16 A Phase IIb Clinical Study to Assess the Pharmacokinetics, Safety, and Efficacy of the Combination Regimen of Elbasvir (EBR)/Grazoprevir (GZR) in Participants Aged 3 to less than 18 Years with Chronic... bad-data
Listed as ongoing, but also has a completion date 2015-003154-40 A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Subjects with Alzheimer’s Disease 2018-09-30 bad-data
Reported results 2015-003187-37 A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) with and without Ribavirin (RBV) in... 2017-01-06 due-trials
Ongoing 2015-003338-29 A Phase II, Open-label, Single-arm, Multicenter Study to Evaluate Efficacy and Safety of Pembrolizumab Monotherapy in Subjects with Advanced Recurrent Ovarian Cancer not-yet-due
Ongoing 2015-003616-20 A Phase IIa Multicenter, Open-Label Clinical Trial to Evaluate the Safety and Efficacy of MK-1439A in Treatment-Naïve HIV-1 Infected Subjects with Selected Non-Nucleoside Reverse Transcriptase Inhibit... not-yet-due
Ongoing 2015-003617-18 Phase IIb, Double-Blinded, Multicenter, Randomized Study to Assess the Effect on Central Nervous System (CNS) Toxicity of Switching from ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Do... not-yet-due
Ongoing 2015-003644-40 Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) (Keynote -199) not-yet-due
Ongoing 2015-003694-15 A Randomized, Double-Blind, Phase III Study of Platinum+Pemetrexed Chemotherapy with or without Pembrolizumab (MK-3475) in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects (KEYNO... not-yet-due
Ongoing 2015-004020-65 A Phase-IV, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of Golimumab (MK-8259 [SCH 900259]) After Treatment Withdrawal, Compared With Continu... not-yet-due
Trial is outside EEC, and reported results 2015-004212-37 A Phase III, Open-Label, Clinical Trial to Study the Safety and Immunogenicity of the Quadrivalent HPV (Types 6, 11, 16, 18) L1 VLP Particle (VLP) Vaccine in 9- to 15-Year-Old Japanese Boys bad-data
Reported results 2015-004224-59 A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared with Metfor... 2018-02-01 due-trials
Reported results 2015-004325-14 A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Study the Efficacy and Safety of MK-8342B (ENG-E2 Vaginal Ring) in Women with Moderate to Severe Primary Dysmenorrhea (with Optional Ext... 2016-09-07 due-trials
Reported results 2015-004326-34 A Phase 3 Randomized, Double-blind, Placebo-Controlled Trial to Study the Efficacy and Safety of MK-8342B (ENG-E2 vaginal ring) in Women with Moderate to Severe Primary Dysmenorrhea. 2016-09-12 due-trials
Ongoing 2015-004566-28 A Phase 2 Study of Pembrolizumab (MK-3475) as Monotherapy in Subjects with Advanced Hepatocellular Carcinoma (KEYNOTE-224) not-yet-due
Ongoing 2015-004567-36 A Phase III Study of Pembrolizumab (MK-3475) vs. Best Supportive Care as Second-Line Therapy in Subjects with Previously Systemically Treated Advanced Hepatocellular Carcinoma (KEYNOTE-240) not-yet-due
Trial is partly outside EEC 2015-004595-29 A Phase 1, Single-Administration Pharmacokinetic and Safety Study of Oral and IV Tedizolid Phosphate in Hospitalized Subjects 2 to <12 Years Old bad-data
Reported results 2015-004990-34 A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of the Continuation of Sitagliptin Compared with the Withdrawal of Sitagliptin Du... 2018-01-30 due-trials
Ongoing 2015-005053-12 A Phase III, Randomized, Open-label, Clinical Trial to Compare Pembrolizumab with Brentuximab Vedotin in Subjects with Relapsed or Refractory Classical Hodgkin Lymphoma not-yet-due
Reported results 2015-005054-36 A Phase-II, Randomized, Placebo-Controlled, Parallel-Group Clinical Trial to Study the Efficacy and Safety of MK-1029 in Adult Subjects with Persistent Asthma That is Uncontrolled While Receiving Mont... 2017-09-06 due-trials
Listed as ongoing, but also has a completion date 2015-005093-38 An Open-Label Phase III Clinical Trial to Study the Immunogenicity and Tolerability of GARDASIL®9 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Adult Women (27- to... 2019-01-21 bad-data
Not reported Terminated 2015-005284-16 A Phase I, Open-Label Study to Investigate the Pharmacokinetics and Pharmacodynamics of Etonogestrel (ENG) and 17ß-Estradiol (E2) in Healthy female Postmenarcheal Adolescents and Healthy Female Adults... 2016-07-14 due-trials
Exempt, with results 2015-005488-18 A Phase IB Dose Exploration Trial with MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Subjects with Selected Advanced Solid Tumors 2017-04-26 not-yet-due
Ongoing 2015-005731-41 A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemotherapy versus Chemotherapy in Subjects with Advanced or Metastatic Urothelial Carcin... not-yet-due
Ongoing 2016-000229-38 A Randomized, Double-Blind, Phase III Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy with or without Pembrolizumab (MK-3475) in First Line Metastatic Squamous Non-small Cell Lung Cancer S... not-yet-due
Ongoing 2016-000588-17 A Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Axitinib versus Sunitinib Monotherapy as a First-line Treatment for Locally Adva... not-yet-due
Ongoing 2016-000589-47 A Phase II Single-arm, Open-label Monotherapy Clinical Trial of Pembrolizumab (MK-3475) in Locally Advanced/Metastatic Renal Cell Carcinoma (mRCC) (KEYNOTE-427) not-yet-due
Ongoing 2016-000620-26 A Phase II/III, Open-label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (MK-3682 + Grazoprevir + MK-8408 Fixed Dose Combination) in Subjects with Chronic Hepa... not-yet-due
Other 2016-000671-25 A Randomized Parallel-Group, Placebo-Controlled, Double-Blind, Event-Driven, Multi- Center Pivotal Phase III Clinical Outcome Trial of Efficacy and Safety of the Oral sGC Stimulator Vericiguat in Subj... not-yet-due
Completed, report not yet due 2016-001117-25 A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Infants 2018-11-30 not-yet-due
Completed, report not yet due 2016-001159-37 A Multi-Site, Open-Label, Partially-Randomized Trial of the Efficacy and Safety of Fixed Dose Elbasvir/Grazoprevir (EBR/GZR) Based Regimens in French Subjects with Chronic Hepatitis C Virus (HCV) Geno... 2018-10-15 not-yet-due
Ongoing 2016-001432-35 A Randomized, Double-Blind, Phase III Study of Pembrolizumab (MK-3475) plus Chemotherapy vs Placebo plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negativ... not-yet-due
Reported results Terminated 2016-002056-25 A Phase IIa, Multicenter, Placebo- and Active-controlled, Randomized, Double-Blind, Clinical Trial to Evaluate the Safety and Efficacy of MK-8521 Compared to Placebo in Subjects with Type 2 Diabetes M... 2017-04-18 due-trials
Exempt 2016-002312-41 Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365) not-yet-due
Reported results 2016-003227-37 A Phase 2, Open-Label Clinical Trial to Study the Efficacy and Safety of 12 weeks of the Combination Regimen of MK-3682 + MK-8408 in Subjects with Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 3, 4, ... 2018-03-05 due-trials
Trial is partly outside EEC 2016-003884-20 A Phase 3 Randomized, Active-comparator-Controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator, in Subjects 3 Months to <12 Years of Age with Acute ... bad-data
Ongoing 2016-003934-25 A Randomized Phase III study of pembrolizumab given concomitantly with chemoradiation and as maintenance therapy versus chemoradiation alone in subjects with locally advanced head and neck squamous ce... not-yet-due
Trial is outside EEC, and reported results 2016-003981-15 A Study in Healthy Neonates of Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured Using a Modified Process bad-data
Trial is partly outside EEC 2016-004153-32 A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Versus Meropenem in Pediatric Subjec... bad-data
Ongoing 2016-004309-15 A Phase 3 Randomized, Double-Blind, Placebo-controlled Trial of Pembrolizumab (MK 3475/SCH900475) in Combination with Etoposide/Platinum (Cisplatin or Carboplatin) for the First-line Treatment of Subj... not-yet-due
Trial is partly outside EEC 2016-004328-43 A Phase 1b, Open-label, Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of MK-7655A in Pediatric Subjects From Birth to Less Than 18 Years of Age With Confirmed or Suspect... bad-data
Ongoing 2016-004351-75 A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (KEYNOTE-564) not-yet-due
Ongoing 2016-004364-20 A Phase 3, Randomized, Double-Blind Study of Pembrolizumab plus Ipilimumab vs Pembrolizumab plus Placebo in Previously Untreated, Stage IV, Metastatic Non-small Cell Lung Cancer Subjects Whose Tumors ... not-yet-due
Trial is outside EEC, and reported results 2016-004392-41 A Study of the Comparative Bioavailability of Two Investigational Pediatric Oral Granule Formulations of Lamivudine and Tenofovir Compared to the Adult Marketed Formulations. bad-data
Ongoing 2016-004408-76 A Phase III, Randomized, Double-blind, Clinical Trial of Pembrolizumab (MK-3475) plus Chemotherapy (XP or FP) versus Placebo plus Chemotherapy (XP or FP) as Neoadjuvant/Adjuvant Treatment for Subjects... not-yet-due
Trial is outside EEC, and reported results 2016-004656-30 A Study of the Comparative Bioavailability of Two Second-Generation Investigational Pediatric Oral Granule Formulations of MK-1439 Compared to the Adult Formulation. bad-data
Trial is outside EEC, and reported results 2016-004728-48 A Study to Evaluate the Comparative Bioavailability of the Investigational Oral Pediatric Minitablet Formulation of MK-1439 Compared to the Adult Formulation of MK-1439 in Healthy Adult Subjects bad-data
Ongoing 2016-004740-11 A Phase III, Randomized, Double-blind Study to Evaluate Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy for Triple ... not-yet-due
Trial is partly outside EEC 2016-004820-41 A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem ... bad-data
Trial is outside EEC, and reported results 2016-005159-25 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and bad-data
Trial is outside EEC, and reported results 2017-000050-18 A Phase II, Multicenter, Open-Label, Noncomparative Study of Raltegravir (MK-0518) in Two Oral Formulations in Combination bad-data
Trial is partly outside EEC 2017-000070-11 A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab (MK 6072, Human Monoclonal Antib... bad-data
Trial is outside EEC, and reported results 2017-000108-42 A Phase IIa Randomized, Double-Blinded, Controlled With GARDASIL™ Clinical Trial to Study the Tolerability and Immunogenicity of V505 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like-Particle [... bad-data
Trial is outside EEC, and reported results 2017-000109-19 A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL™, Dose-Ranging Study of Octavalent Human Papillomavirus (HPV) (Types 6, 11, 16, 18, 31, 45, 52, and 58) L... bad-data
Trial is outside EEC, and reported results 2017-000110-35 Evaluation of Safety and Immunogenicity of GARDASIL™ in Healthy Females Between 9 and 26 Years of Age in SubSaharan Africa. bad-data
Trial is outside EEC, and reported results 2017-000111-16 Evaluation of Safety, Tolerability and Immunogenicity of Quadrivalent HPV Vaccine in healthy females 9 to 15 years of age in India. bad-data
Trial is outside EEC, and reported results 2017-000112-42 A Phase II Double-Blind Comparative Study of V501 in Females Aged 9 to 17 Years bad-data
Trial is outside EEC, and reported results 2017-000186-76 A Phase III, Multi-Center, Randomized, Parallel-Group, Placebo-Controlled and Double- Blind Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects with Perennial bad-data
Ongoing 2017-000187-15 A Phase 4 Randomized, Active-Comparator Controlled Clinical Trial to Study the Safety of Sugammadex (MK-8616) for the Reversal of Neuromuscular Blockade Induced by Either Rocuronium Bromide or Vecuron... not-yet-due
Completed, report not yet due 2017-000188-33 A Phase 4 Randomized, Active-Comparator Controlled Trial to Study the Efficacy and Safety of Sugammadex (MK-8616) for the Reversal of Neuromuscular Blockade Induced by Either Rocuronium Bromide or Vec... 2019-01-31 not-yet-due
Trial is outside EEC, and reported results 2017-000263-32 A Double-Blind, Randomized, Placebo-Controlled, Safety and Tolerability Study of Live Pentavalent Human-Bovine Rotavirus bad-data
Trial is outside EEC, and reported results 2017-000264-15 A phase III randomized, placebo-controlled clinical trial to study the efficacy and safety of V260 in healthy infants in Japan bad-data
Trial is outside EEC, and reported results 2017-000277-37 Post-marketing, Randomized, Open-label Study to Assess the Immunogenicity and Safety of Concomitant Administration of V260 and Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IP... bad-data
Ongoing 2017-000437-32 A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose- Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in... not-yet-due
Ongoing 2017-000472-28 A Phase 2a, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of MK-7264 on Acute Cough in Participants with Induced Viral Upper Respiratory Tract Infecti... not-yet-due
Ongoing 2017-000537-31 A Phase 3, Randomized, Double-blind, Placebo-controlled, 12-month Study to Evaluate the Efficacy and Safety of MK-7264 in Adult Participants with Chronic Cough (PN027) not-yet-due
Ongoing 2017-000594-37 A Phase 2, Open-label, Single arm Study to Evaluate the Safety and Efficacy of Pembrolizumab in Participants with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) not-yet-due
Trial is outside EEC, and reported results 2017-000608-13 A phase III multicentre, parallel-group, randomized, placebo-controlled, double-blind clinical trial to study the efficacy and safety of MK-4117 in Japanese subjects with chronic urticaria. bad-data
Trial is outside EEC, and reported results 2017-000610-26 A Phase III, Multicenter, Open-Label Long-Term Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects With Eczema/Dermatitis and Dermal Pruritus. bad-data
Ongoing 2017-000692-92 A Phase 4 Double-Blinded, Randomized, Active Comparator-Controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in ... not-yet-due
No trial status on register 2017-000693-11 A Phase 4 Double-blinded, Randomized, Active Comparator-controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in ... bad-data
Trial is partly outside EEC 2017-000953-38 A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Oral and IV Tedizolid Phosphate (MK-1986) in Inpatients Under 2 Years Old bad-data
Ongoing 2017-000958-19 A Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial of Pembrolizumab (MK-3475) in Combination with Cisplatin and 5-Fluorouracil versus Placebo in Combination with Cisplatin and 5-F... not-yet-due
Ongoing 2017-001055-30 A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of MK-8228 (Letermovir) Versus Valganciclovir for the Prevention of Human Cytomegalovirus ... not-yet-due
Ongoing 2017-001139-38 A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for StageIII-IVA Resectable Locoregionally Advan... not-yet-due
Trial is outside EEC 2017-001205-33 A Phase III Open-label Safety and Immunogenicity Study of GARDASIL™9 Administered to 9- to 26-Year-Old Females and Males in Vietnam bad-data
Trial is outside EEC, and reported results 2017-001443-13 A Phase III Double-Blind, Randomized, Multicenter, Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, Varicella (MMRV) Vaccine Made with an Alternati... bad-data
Trial is outside EEC, and reported results 2017-001444-35 A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX™ New Seed Process (NSP) Administered Concomitantly with M-M-R™ II bad-data
Listed as ongoing, but also has a completion date 2017-001463-21 A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of the Combination Regimen of MK-3682B (Grazoprevir/Ruzasvir/Uprifosbuvir) in Participants with Chronic Hepatitis C Virus Genotype 3 Infect... 2017-10-06 bad-data
Ongoing 2017-001832-21 A Phase III, Randomized, Double-blind Trial of Platinum Doublet Chemotherapy +/-Pembrolizumab (MK-3475) as Neoadjuvant/Adjuvant Therapy for Participants with Resectable Stage IIB or IIIA Non-small Cel... not-yet-due
Ongoing 2017-001909-32 A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by Administration of PNEUMOVAX™23 Eight W... not-yet-due
Other 2017-003134-85 A Phase 2 Precision Oncology Study of Biomarker-Directed, Pembrolizumab- (MK-3475, SCH 900475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (KEYNOTE-495; KeyImPaCT) not-yet-due
Ongoing 2017-003559-49 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-month Study to Evaluate the Effic acy and Safety of MK-7264 in Adult Participants with Chronic Cough (PN030) not-yet-due
Ongoing 2017-004024-30 A Phase 3, Multicenter, Randomized, Double-blind, Active Comparatorcontrolled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by Administration of PNEUMOVAX™23 One Year... not-yet-due
Ongoing 2017-004188-11 A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell L... not-yet-due
Ongoing 2017-004233-86 Double-Blind, Randomized, Placebo-Controlled Phase 2b, Multi-center Study to Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a 2-Dose and a 3- Dose Regimen of V160 (Cytomegalovirus [... not-yet-due
Ongoing 2017-004417-42 A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab T... not-yet-due
Ongoing 2017-004869-27 A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estro... not-yet-due
Exempt 2017-005062-21 A Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK 1654 in Pre-Term and Full-Term Infants not-yet-due
Ongoing 2018-000066-11 A Phase 3, Randomized, Double-blind, Active Comparator-controlled, Multicenter Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Recipients of Allogeneic Hematopoietic... not-yet-due
Ongoing 2018-000224-34 A Phase III, Randomized, Double-blind Trial Comparing Trastuzumab Plus Chemotherapy and Pembrolizumab With Trastuzumab Plus Chemotherapy and Placebo as First-line Treatment in Participants With HER2 P... not-yet-due
Other 2018-000669-35 Adjuvant Therapy with Pembrolizumab versus Placebo in Resected High-risk Stage II Melanoma: A Randomized, Double-blind Phase 3 Study (KEYNOTE 716) not-yet-due
Ongoing 2018-000714-37 A Phase 2 Trial of Pembrolizumab (MK-3475) in Combination with Platinum Doublet Chemotherapy and Radiotherapy for Participants with Unresectable, Locally Advanced Stage III Non-Small Cell Lung Cancer ... not-yet-due
Ongoing 2018-001038-17 A Phase 3 randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of letermovir (LET) prophylaxis when extended from 100 days to 200 days post transplant in cyt... not-yet-due
Ongoing 2018-001098-26 A Phase 2a, Proof of Concept, Randomized, Double-blind, Placebo-controlled Clinical Trial, to Evaluate the Efficacy and Safety of MK-7264 in Women with Moderate to Severe Endometriosis-related Pain not-yet-due
Trial is outside EEC 2018-001151-12 A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13™ with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRE... bad-data
Ongoing 2018-001152-35 A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children with Sickle Cell Disease (PNEU–SICKLE) not-yet-due
Trial is partly outside EEC 2018-001326-25 A Phase 2b open-label, single-arm study to evaluate pharmacokinetics, efficacy, safety and tolerability of letermovir in pediatric participants from birth to less than 18 years of age at risk of devel... bad-data
Ongoing 2018-001440-53 A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Chemotherapy Plus Placebo for the First-Line Treatment of Persistent, Recurrent, or Met... not-yet-due
Exempt 2018-001461-16 A Phase 1/Phase 2 Clinical Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants with Hematologic Malignancies not-yet-due
Ongoing 2018-001757-27 A Phase 3, randomized, double-blind clinical study of pembrolizumab (MK-3475) plus chemotherapy versus placebo plus chemotherapy as first-line treatment in participants with HER2 negative, previously ... not-yet-due
Ongoing 2018-001967-22 A Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette- Guerin (BCG) in Participants with High-ri... not-yet-due
Ongoing 2018-001973-25 A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First- Line Treatment of BRCA non-mutated Advanced Epith... not-yet-due
Ongoing 2018-001974-76 A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanc... not-yet-due
Ongoing 2018-002518-10 A Multicenter, Open-label, Phase 2 Trial to Assess the Efficacy and Safety of Lenvatinib (E7080/MK-7902) in Combination with Pembrolizumab (MK-3475) in Participants with Advanced Melanoma Previously E... not-yet-due
Ongoing 2018-002520-16 A Phase 3 Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) and Lenvatinib (E7080/MK-7902) Versus Pembrolizumab Alone as First-line Intervention in Pa... not-yet-due
Ongoing 2018-002598-22 A Phase II Trial to Investigate Genetic Markers of Response to Pembrolizumab (MK-3475, SCH 900475) Combined with Chemotherapy as a First-line Treatment for Non-Small Cell Lung Cancer (KEYNOTE-782) not-yet-due
Other 2018-002601-57 A Phase 3 Open-label, Single Arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) as First-line Therapy in Participants With Advanced Merkel Cell Carcinoma (KEYNOTE-913)) not-yet-due
Ongoing 2018-002983-26 Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib (E7080/MK- 7902) in Combination with Pembrolizumab (MK-3475) Versus... not-yet-due
Ongoing 2018-003007-19 A Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer not-yet-due
Other 2018-003308-38 A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety and Tolerability of V114 in Healthy Infants (PNEU - LINK) not-yet-due
Ongoing 2018-003706-88 A Phase 3, Multicenter, Randomized, Double-blind, Active Comparatorcontrolled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Catch -up Vaccination Regimens of V114 in Healthy Infant... not-yet-due
Ongoing 2018-003747-37 A Multicenter, Open-label Phase 2 Study of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) in Previously Treated Subjects with Selected Solid Tumors (LEAP-005) not-yet-due
Ongoing 2018-003752-21 A Phase 3, Randomized, Double-blind Study to Compare the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Lenvatinib (E7080/MK-7902) Versus Pembrolizumab and Placebo as First Line Tr... not-yet-due
Ongoing 2018-003791-12 A Phase 3, multicenter, randomized, open-label trial to compare the efficacy and safety of pembrolizumab (MK-3475) in combination with lenvatinib (E7080/MK-7902) versus docetaxel in previously treated... not-yet-due
Ongoing 2018-003794-98 A Phase 3, randomized, double-blind trial of pembrolizumab (MK-3475) with or without lenvatinib (E7080/MK-7902) in participants with treatment-naïve, metastatic non-small cell lung cancer (NSCLC) whos... not-yet-due
Ongoing 2018-003808-39 A Phase 3, Randomized Double Blind Study to Evaluate Peri-operative Pembrolizumab (MK-3475) + Neoadjuvant Chemotherapy versus Perioperative Placebo + Neoadjuvant Chemotherapy in Cisplatin-Eligible Par... not-yet-due
Ongoing 2018-003809-26 A Phase 3 Randomized Study of Cystectomy plus Perioperative Pembrolizumab versus Cystectomy Alone in Cisplatin-ineligible Participants with Muscleinvasive Bladder Cancer (KEYNOTE-905) not-yet-due
Ongoing 2018-003824-35 A Phase 3 Randomized, Placebo-controlled Study to Evaluate the Safety and Efficacy of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) with or without Lenvatinib (E7080/MK-7902) as First-l... not-yet-due
Ongoing 2018-004116-22 A Phase 3, Randomized, Double-blind Study of Pembrolizumab (MK-3475) Plus Docetaxel Plus Prednisone versus Placebo Plus Docetaxel Plus Prednisone in Participants with Chemotherapy-naïve Metastatic Cas... not-yet-due
Ongoing 2018-004118-16 A Phase 3, Randomized Open-label Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castrationresistant Prostate Cancer (mCRPC) W... not-yet-due
Ongoing 2018-004320-11 A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab (MK-3475) in Participants with Medic... not-yet-due
Ongoing 2018-004800-20 A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete Rad... not-yet-due

Related organisations

Over time organisations can merge, or split.

We think Merck Sharp & Dohme (MSD) is now also responsible for the trials of: